Mechanisms of allergen-specific immunotherapy: Multiple suppressor factors at work in immune tolerance to allergens
Allergen-specific immunotherapy (AIT) has been used for more than 100 years as a desensitizing therapy for IgE-mediated allergic diseases and represents a potentially curative way of treatment. The mechanisms of action of AIT include the induction of very early desensitization of mast cells and baso...
Gespeichert in:
| Veröffentlicht in: | Journal of allergy and clinical immunology Jg. 133; H. 3; S. 621 - 631 |
|---|---|
| Hauptverfasser: | , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
New York, NY
Elsevier Inc
01.03.2014
Elsevier Elsevier Limited |
| Schlagworte: | |
| ISSN: | 0091-6749, 1097-6825, 1097-6825 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Allergen-specific immunotherapy (AIT) has been used for more than 100 years as a desensitizing therapy for IgE-mediated allergic diseases and represents a potentially curative way of treatment. The mechanisms of action of AIT include the induction of very early desensitization of mast cells and basophils; generation of regulatory T and regulatory B (Breg) cell responses; regulation of IgE and IgG4; decreases in numbers and activity of eosinophils and mast cells in mucosal allergic tissues; and decreases in the activity of basophils in circulation. Skewing of allergen-specific effector T and effector B cells to a regulatory phenotype appears as a key event in the course of AIT and normal immune response to allergens. Recently, inducible IL-10–secreting Breg cells were also demonstrated to contribute to allergen tolerance through suppression of effector T cells and selective induction of IgG4 isotype antibodies. Allergen-specific regulatory T and Breg cells orchestrate a general immunoregulatory activity, which can be summarized as suppression of cytokines from inflammatory dendritic cells; suppression of effector TH1, TH2, and TH17 cells; suppression of allergen-specific IgE and induction of IgG4; and suppression of migration of mast cells, basophils, eosinophils, and effector T cells to tissues. A detailed knowledge of the mechanisms of AIT is not only important in designing the prevention and treatment of allergic diseases but might also find applications in the treatment of autoimmune diseases, organ transplantation, chronic infection, and cancer. |
|---|---|
| AbstractList | Allergen-specific immunotherapy (AIT) has been used for more than 100 years as a desensitizing therapy for IgE-mediated allergic diseases and represents a potentially curative way of treatment. The mechanisms of action of AIT include the induction of very early desensitization of mast cells and basophils; generation of regulatory T and regulatory B (Breg) cell responses; regulation of IgE and IgG4; decreases in numbers and activity of eosinophils and mast cells in mucosal allergic tissues; and decreases in the activity of basophils in circulation. Skewing of allergen-specific effector T and effector B cells to a regulatory phenotype appears as a key event in the course of AIT and normal immune response to allergens. Recently, inducible IL-10-secreting Breg cells were also demonstrated to contribute to allergen tolerance through suppression of effector T cells and selective induction of IgG4 isotype antibodies. Allergen-specific regulatory T and Breg cells orchestrate a general immunoregulatory activity, which can be summarized as suppression of cytokines from inflammatory dendritic cells; suppression of effector TH1, TH2, and TH17 cells; suppression of allergen-specific IgE and induction of IgG4; and suppression of migration of mast cells, basophils, eosinophils, and effector T cells to tissues. A detailed knowledge of the mechanisms of AIT is not only important in designing the prevention and treatment of allergic diseases but might also find applications in the treatment of autoimmune diseases, organ transplantation, chronic infection, and cancer. Allergen-specific immunotherapy (AIT) has been used for more than 100 years as a desensitizing therapy for IgE-mediated allergic diseases and represents a potentially curative way of treatment. The mechanisms of action of AIT include the induction of very early desensitization of mast cells and basophils; generation of regulatory T and regulatory B (Breg) cell responses; regulation of IgE and IgG4; decreases in numbers and activity of eosinophils and mast cells in mucosal allergic tissues; and decreases in the activity of basophils in circulation. Skewing of allergen-specific effector T and effector B cells to a regulatory phenotype appears as a key event in the course of AIT and normal immune response to allergens. Recently, inducible IL-10-secreting Breg cells were also demonstrated to contribute to allergen tolerance through suppression of effector T cells and selective induction of IgG4isotype antibodies. Allergen-specific regulatory T and Breg cells orchestrate a general immunoregulatory activity, which can be summarized as suppression of cytokines from inflammatory dendritic cells; suppression of effector TH1, TH2, and TH17 cells; suppression of allergen-specific IgE and induction of IgG4; and suppression of migration of mast cells, basophils, eosinophils, and effector T cells to tissues. A detailed knowledge of the mechanisms of AIT is not only important in designing the prevention and treatment of allergic diseases but might also find applications in the treatment of autoimmune diseases, organ transplantation, chronic infection, and cancer. Allergen-specific immunotherapy (AIT) has been used for more than 100 years as a desensitizing therapy for IgE-mediated allergic diseases and represents a potentially curative way of treatment. The mechanisms of action of AIT include the induction of very early desensitization of mast cells and basophils; generation of regulatory T and regulatory B (Breg) cell responses; regulation of IgE and IgG4; decreases in numbers and activity of eosinophils and mast cells in mucosal allergic tissues; and decreases in the activity of basophils in circulation. Skewing of allergen-specific effector T and effector B cells to a regulatory phenotype appears as a key event in the course of AIT and normal immune response to allergens. Recently, inducible IL-10-secreting Breg cells were also demonstrated to contribute to allergen tolerance through suppression of effector T cells and selective induction of IgG4 isotype antibodies. Allergen-specific regulatory T and Breg cells orchestrate a general immunoregulatory activity, which can be summarized as suppression of cytokines from inflammatory dendritic cells; suppression of effector TH1, TH2, and TH17 cells; suppression of allergen-specific IgE and induction of IgG4; and suppression of migration of mast cells, basophils, eosinophils, and effector T cells to tissues. A detailed knowledge of the mechanisms of AIT is not only important in designing the prevention and treatment of allergic diseases but might also find applications in the treatment of autoimmune diseases, organ transplantation, chronic infection, and cancer. Allergen-specific immunotherapy (AIT) has been used for more than 100 years as a desensitizing therapy for IgE-mediated allergic diseases and represents a potentially curative way of treatment. The mechanisms of action of AIT include the induction of very early desensitization of mast cells and basophils; generation of regulatory T and regulatory B (Breg) cell responses; regulation of IgE and IgG4; decreases in numbers and activity of eosinophils and mast cells in mucosal allergic tissues; and decreases in the activity of basophils in circulation. Skewing of allergen-specific effector T and effector B cells to a regulatory phenotype appears as a key event in the course of AIT and normal immune response to allergens. Recently, inducible IL-10-secreting Breg cells were also demonstrated to contribute to allergen tolerance through suppression of effector T cells and selective induction of IgG4 isotype antibodies. Allergen-specific regulatory T and Breg cells orchestrate a general immunoregulatory activity, which can be summarized as suppression of cytokines from inflammatory dendritic cells; suppression of effector TH1, TH2, and TH17 cells; suppression of allergen-specific IgE and induction of IgG4; and suppression of migration of mast cells, basophils, eosinophils, and effector T cells to tissues. A detailed knowledge of the mechanisms of AIT is not only important in designing the prevention and treatment of allergic diseases but might also find applications in the treatment of autoimmune diseases, organ transplantation, chronic infection, and cancer.Allergen-specific immunotherapy (AIT) has been used for more than 100 years as a desensitizing therapy for IgE-mediated allergic diseases and represents a potentially curative way of treatment. The mechanisms of action of AIT include the induction of very early desensitization of mast cells and basophils; generation of regulatory T and regulatory B (Breg) cell responses; regulation of IgE and IgG4; decreases in numbers and activity of eosinophils and mast cells in mucosal allergic tissues; and decreases in the activity of basophils in circulation. Skewing of allergen-specific effector T and effector B cells to a regulatory phenotype appears as a key event in the course of AIT and normal immune response to allergens. Recently, inducible IL-10-secreting Breg cells were also demonstrated to contribute to allergen tolerance through suppression of effector T cells and selective induction of IgG4 isotype antibodies. Allergen-specific regulatory T and Breg cells orchestrate a general immunoregulatory activity, which can be summarized as suppression of cytokines from inflammatory dendritic cells; suppression of effector TH1, TH2, and TH17 cells; suppression of allergen-specific IgE and induction of IgG4; and suppression of migration of mast cells, basophils, eosinophils, and effector T cells to tissues. A detailed knowledge of the mechanisms of AIT is not only important in designing the prevention and treatment of allergic diseases but might also find applications in the treatment of autoimmune diseases, organ transplantation, chronic infection, and cancer. Allergen-specific immunotherapy (AIT) has been used for more than 100 years as a desensitizing therapy for IgE-mediated allergic diseases and represents a potentially curative way of treatment. The mechanisms of action of AIT include the induction of very early desensitization of mast cells and basophils; generation of regulatory T and regulatory B (Breg) cell responses; regulation of IgE and IgG4 ; decreases in numbers and activity of eosinophils and mast cells in mucosal allergic tissues; and decreases in the activity of basophils in circulation. Skewing of allergen-specific effector T and effector B cells to a regulatory phenotype appears as a key event in the course of AIT and normal immune response to allergens. Recently, inducible IL-10–secreting Breg cells were also demonstrated to contribute to allergen tolerance through suppression of effector T cells and selective induction of IgG4 isotype antibodies. Allergen-specific regulatory T and Breg cells orchestrate a general immunoregulatory activity, which can be summarized as suppression of cytokines from inflammatory dendritic cells; suppression of effector TH 1, TH 2, and TH 17 cells; suppression of allergen-specific IgE and induction of IgG4 ; and suppression of migration of mast cells, basophils, eosinophils, and effector T cells to tissues. A detailed knowledge of the mechanisms of AIT is not only important in designing the prevention and treatment of allergic diseases but might also find applications in the treatment of autoimmune diseases, organ transplantation, chronic infection, and cancer. |
| Author | Akdis, Cezmi A. Akdis, Mübeccel |
| Author_xml | – sequence: 1 givenname: Mübeccel surname: Akdis fullname: Akdis, Mübeccel email: akdism@siaf.uzh.ch – sequence: 2 givenname: Cezmi A. surname: Akdis fullname: Akdis, Cezmi A. email: akdisac@siaf.uzh.ch |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28383866$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/24581429$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkl1rFDEUhoNU7Lb6CwQZEMGbWZNJJpMoCqX4BS1eqNchkzljs51JxiRj2X9vhl1bWJAlF_nged9wznnP0InzDhB6TvCaYMLfbNYbbey6woSuSZXfhHiEVgTLpuSiqk_QCmNJSt4weYrOYtzgfKdCPkGnFasFYZVcoXgN5kY7G8dY-L7QwwDhF7gyTmBsb01hx3F2Pt1A0NP2bXE9D8lOAxRxnqYAMfpQ9NokH2KhU3Hnw21h3U4FRfLZTjuznO6941P0uNdDhGf7_Rz9_PTxx-WX8urb56-XF1el4RVNZYcpNEY2QJuuNT2mmJu2Y4bxpu5a3EIre0mE4bXpTCsrwH0n-hq3WleyxYKeo9c73yn43zPEpEYbDQyDduDnqAivsxcTgh5Ha8IYXciMvjxAN34OLheSDRlrBKvrhXqxp-Z2hE5NwY46bNW_zmfg1R7Q0eihX9pk4wMnaF6cZ47uOBN8jAH6e4RgteRAbdSSA7XkQJFKLTnIKnmgMjbpZL1LQdvhiPb9Tgt5Nn8sBBWNhTzEzgYwSXXeHtF_ONCbwTqbi7yFLcSHbqlYKay-LyldQkoYxgTzJhu8-7_B0e__AqPp-AQ |
| CODEN | JACIBY |
| CitedBy_id | crossref_primary_10_4168_aair_2016_8_3_191 crossref_primary_10_1371_journal_pone_0107492 crossref_primary_10_18621_eurj_1086549 crossref_primary_10_1155_2018_3479185 crossref_primary_10_1155_2018_6012053 crossref_primary_10_1111_all_13311 crossref_primary_10_1111_all_13553 crossref_primary_10_1016_j_anai_2022_04_028 crossref_primary_10_1007_s40629_018_0067_x crossref_primary_10_2217_imt_2017_0138 crossref_primary_10_1080_13543784_2017_1290079 crossref_primary_10_1074_jbc_RA118_005418 crossref_primary_10_1016_j_ijpharm_2018_07_047 crossref_primary_10_1111_all_13684 crossref_primary_10_1007_s12268_016_0749_1 crossref_primary_10_1016_j_jaci_2016_09_055 crossref_primary_10_1371_journal_pone_0178563 crossref_primary_10_1016_j_anai_2022_12_009 crossref_primary_10_1016_j_aller_2017_05_001 crossref_primary_10_3390_vetsci1030136 crossref_primary_10_1007_s40521_018_0170_8 crossref_primary_10_1016_j_intimp_2020_107046 crossref_primary_10_1038_s41598_024_73575_6 crossref_primary_10_1080_1744666X_2018_1467757 crossref_primary_10_3390_biomedicines10112825 crossref_primary_10_1016_j_aller_2019_10_003 crossref_primary_10_1111_all_13573 crossref_primary_10_1007_s11654_015_5139_5 crossref_primary_10_1007_s11882_018_0766_x crossref_primary_10_2217_imt_2021_0325 crossref_primary_10_1016_j_pharmthera_2022_108115 crossref_primary_10_1002_eji_201847883 crossref_primary_10_1007_s00405_019_05656_6 crossref_primary_10_3390_vaccines10071037 crossref_primary_10_1111_all_12490 crossref_primary_10_1111_jam_14524 crossref_primary_10_1016_j_jaci_2016_07_006 crossref_primary_10_1016_j_clim_2023_109853 crossref_primary_10_1016_j_jaci_2016_07_007 crossref_primary_10_1586_1744666X_2015_977260 crossref_primary_10_1111_pai_13042 crossref_primary_10_1002_iid3_91 crossref_primary_10_1186_s13223_016_0142_0 crossref_primary_10_1007_s40521_017_0113_9 crossref_primary_10_1016_j_waojou_2023_100807 crossref_primary_10_1007_s40136_020_00284_9 crossref_primary_10_1016_j_waojou_2020_100489 crossref_primary_10_1080_21645515_2022_2066424 crossref_primary_10_1111_all_14203 crossref_primary_10_1111_all_15659 crossref_primary_10_1016_j_blre_2018_02_003 crossref_primary_10_1111_cea_12684 crossref_primary_10_1111_cea_13891 crossref_primary_10_1186_s13052_018_0519_4 crossref_primary_10_4049_jimmunol_2100988 crossref_primary_10_1080_10408398_2016_1275519 crossref_primary_10_1016_j_intimp_2021_107770 crossref_primary_10_36303_SAGP_2020_1_0010 crossref_primary_10_1080_09540105_2021_2005545 crossref_primary_10_3892_mmr_2020_11084 crossref_primary_10_3390_ijms232314905 crossref_primary_10_1111_all_13486 crossref_primary_10_1111_all_13363 crossref_primary_10_1016_j_jaci_2017_11_005 crossref_primary_10_3920_BM2017_0180 crossref_primary_10_1586_14760584_2014_948861 crossref_primary_10_22141_2224_0551_20_4_2025_1846 crossref_primary_10_1016_j_jaci_2016_10_036 crossref_primary_10_3390_ph17121580 crossref_primary_10_1016_j_reval_2020_07_003 crossref_primary_10_1111_cea_12555 crossref_primary_10_1111_cea_12554 crossref_primary_10_1159_000479694 crossref_primary_10_1016_j_waojou_2021_100597 crossref_primary_10_3390_medicina57111229 crossref_primary_10_1016_j_jaci_2015_08_044 crossref_primary_10_1016_j_tvjl_2016_11_013 crossref_primary_10_1038_s42003_020_01466_3 crossref_primary_10_1159_000471852 crossref_primary_10_1007_s00405_025_09498_3 crossref_primary_10_1186_s40733_015_0006_2 crossref_primary_10_3389_fimmu_2024_1411392 crossref_primary_10_1186_s12989_015_0095_3 crossref_primary_10_4168_aair_2020_12_6_949 crossref_primary_10_1016_j_jaci_2015_07_031 crossref_primary_10_1038_srep19224 crossref_primary_10_1111_all_13138 crossref_primary_10_2196_50846 crossref_primary_10_1038_nri_2016_111 crossref_primary_10_3389_fpls_2020_00344 crossref_primary_10_1097_ACI_0000000000000088 crossref_primary_10_1177_1753465816669662 crossref_primary_10_1186_1824_7288_40_S1_A79 crossref_primary_10_1016_j_intimp_2019_02_045 crossref_primary_10_1007_s15007_016_1042_9 crossref_primary_10_1186_s40413_016_0106_3 crossref_primary_10_1016_j_jaip_2021_10_057 crossref_primary_10_1038_mi_2016_46 crossref_primary_10_1007_s11882_015_0523_3 crossref_primary_10_1016_j_anpede_2018_01_002 crossref_primary_10_1016_j_jaci_2014_06_005 crossref_primary_10_1016_j_reval_2019_02_210 crossref_primary_10_1080_09540105_2015_1048787 crossref_primary_10_1186_s40413_018_0191_6 crossref_primary_10_3389_fped_2022_1050560 crossref_primary_10_1007_s11882_014_0478_9 crossref_primary_10_3389_fimmu_2021_613461 crossref_primary_10_2147_JAA_S267522 crossref_primary_10_3390_vaccines9030249 crossref_primary_10_1186_s13601_018_0226_7 crossref_primary_10_1186_s40413_015_0063_2 crossref_primary_10_1016_j_aller_2016_10_017 crossref_primary_10_3390_vaccines8020237 crossref_primary_10_3389_fimmu_2025_1516068 crossref_primary_10_1038_s41385_020_00358_3 crossref_primary_10_1111_all_12996 crossref_primary_10_1111_cea_13323 crossref_primary_10_1111_cea_13686 crossref_primary_10_1016_j_aller_2016_09_001 crossref_primary_10_2217_imt_2021_0133 crossref_primary_10_1111_cei_12442 crossref_primary_10_1016_j_biomaterials_2017_07_019 crossref_primary_10_1007_s00105_014_2817_0 crossref_primary_10_1111_all_12883 crossref_primary_10_1111_all_12647 crossref_primary_10_3389_fimmu_2018_01244 crossref_primary_10_1016_j_jff_2021_104858 crossref_primary_10_1016_j_jaci_2020_07_011 crossref_primary_10_1016_j_jaci_2017_04_019 crossref_primary_10_1016_j_jaci_2016_02_004 crossref_primary_10_1016_j_mcna_2019_09_001 crossref_primary_10_1080_1744666X_2018_1504679 crossref_primary_10_3109_07357907_2015_1010089 crossref_primary_10_1007_s11882_016_0658_x crossref_primary_10_1016_j_jaci_2016_03_024 crossref_primary_10_1016_j_jaci_2022_01_011 crossref_primary_10_1177_20420188251362093 crossref_primary_10_1111_all_13980 crossref_primary_10_1111_all_12533 crossref_primary_10_1007_s40629_016_0096_2 crossref_primary_10_1016_j_vaccine_2018_03_076 crossref_primary_10_1111_all_13989 crossref_primary_10_1111_all_14716 crossref_primary_10_1084_jem_20190472 crossref_primary_10_1111_imr_12555 crossref_primary_10_3390_toxins12060379 crossref_primary_10_1111_pim_12142 crossref_primary_10_1586_17512433_2016_1157017 crossref_primary_10_3389_fmicb_2018_01449 crossref_primary_10_1002_alr_23090 crossref_primary_10_1111_sji_12881 crossref_primary_10_1111_all_12661 crossref_primary_10_1016_j_jaci_2015_09_015 crossref_primary_10_1016_j_jaci_2016_02_029 crossref_primary_10_1016_j_jaci_2016_02_024 crossref_primary_10_1111_all_15817 crossref_primary_10_3390_jof11030181 crossref_primary_10_1111_cea_13254 crossref_primary_10_1016_j_jaci_2014_08_051 crossref_primary_10_15789_1563_0625_ASI_3166 crossref_primary_10_1586_1744666X_2016_1103182 crossref_primary_10_1007_s00005_018_0526_6 crossref_primary_10_1248_bpb_b25_00138 crossref_primary_10_1016_j_jaip_2019_06_003 crossref_primary_10_1016_S1634_7358_25_50880_X crossref_primary_10_1111_all_13763 crossref_primary_10_1111_all_12796 crossref_primary_10_1007_s12519_016_0022_1 crossref_primary_10_1111_all_15709 crossref_primary_10_1016_j_jaci_2017_10_010 crossref_primary_10_3390_ijms24119771 crossref_primary_10_1097_JD9_0000000000000242 crossref_primary_10_1111_cea_14575 crossref_primary_10_4049_jimmunol_1501510 crossref_primary_10_1016_j_jaci_2016_02_010 crossref_primary_10_1016_j_waojou_2023_100754 crossref_primary_10_1631_jzus_B2200047 crossref_primary_10_1007_s11095_021_03020_0 crossref_primary_10_1016_j_jaci_2017_11_053 crossref_primary_10_1016_j_resp_2014_11_010 crossref_primary_10_1016_j_intimp_2018_06_014 crossref_primary_10_1016_j_jaci_2016_01_001 crossref_primary_10_1016_j_jaip_2023_11_031 crossref_primary_10_1016_j_molimm_2020_06_019 crossref_primary_10_1007_s00431_019_03444_2 crossref_primary_10_3389_fimmu_2019_01543 crossref_primary_10_1016_j_molimm_2023_02_004 crossref_primary_10_1111_1756_185X_14892 crossref_primary_10_1016_j_aller_2017_03_005 crossref_primary_10_1007_s40629_018_0069_8 crossref_primary_10_1016_j_intimp_2022_109612 crossref_primary_10_1016_S1636_5410_25_50682_7 crossref_primary_10_1186_s12948_017_0079_y crossref_primary_10_1159_000368777 crossref_primary_10_1038_s41467_024_54684_2 crossref_primary_10_1016_j_foodchem_2021_131588 crossref_primary_10_3390_nu13051638 crossref_primary_10_2500_jfa_2025_7_250007 crossref_primary_10_1111_all_12576 crossref_primary_10_1111_all_12697 crossref_primary_10_15789_1563_0625_CII_3064 crossref_primary_10_1159_000486960 crossref_primary_10_1016_j_alergo_2015_02_001 crossref_primary_10_1111_cea_13469 crossref_primary_10_1183_13993003_01824_2014 crossref_primary_10_1371_journal_pone_0150463 crossref_primary_10_3390_ijms222111898 crossref_primary_10_1016_j_immuni_2018_10_016 crossref_primary_10_4049_jimmunol_1601028 crossref_primary_10_1186_s12876_016_0450_3 crossref_primary_10_3345_cep_2022_00479 crossref_primary_10_1016_j_biopha_2020_111029 crossref_primary_10_1016_j_vaccine_2015_05_106 crossref_primary_10_1586_14760584_2015_1050385 crossref_primary_10_1016_j_cca_2018_11_036 crossref_primary_10_2217_epi_2016_0162 crossref_primary_10_1007_s40521_021_00280_4 crossref_primary_10_1002_jcp_29941 crossref_primary_10_3390_cells11040622 crossref_primary_10_1186_1939_4551_7_23 crossref_primary_10_3390_toxins17080373 crossref_primary_10_1016_j_semarthrit_2018_10_007 crossref_primary_10_3390_vaccines12020208 crossref_primary_10_1016_j_intimp_2014_05_033 crossref_primary_10_1007_s40629_019_0097_z crossref_primary_10_1016_j_jaci_2014_12_1866 crossref_primary_10_1007_s11882_014_0486_9 crossref_primary_10_1111_imr_13386 crossref_primary_10_1186_s12917_016_0805_6 crossref_primary_10_3390_biomedicines10102486 crossref_primary_10_1016_j_jaci_2023_12_028 crossref_primary_10_1038_cmi_2017_26 crossref_primary_10_1074_jbc_M114_567875 crossref_primary_10_1007_s11882_015_0587_0 crossref_primary_10_1186_1939_4551_7_14 crossref_primary_10_1007_s15007_019_1847_4 crossref_primary_10_1016_j_jaci_2016_05_023 crossref_primary_10_1016_j_jaci_2014_01_007 crossref_primary_10_1016_j_jaci_2017_07_036 crossref_primary_10_1159_000514157 crossref_primary_10_1186_s12014_023_09431_y crossref_primary_10_1038_JID_2015_384 crossref_primary_10_1016_j_jaci_2015_03_010 crossref_primary_10_1002_alr_22384 crossref_primary_10_1111_cea_13157 crossref_primary_10_1016_j_iac_2019_09_003 crossref_primary_10_1016_j_smim_2017_09_003 crossref_primary_10_12688_f1000research_9399_1 crossref_primary_10_2217_imt_2019_0009 crossref_primary_10_1016_j_imlet_2018_10_005 crossref_primary_10_1371_journal_pone_0183398 crossref_primary_10_1084_jem_20220964 crossref_primary_10_1016_j_jaci_2015_03_001 crossref_primary_10_3389_fped_2017_00117 crossref_primary_10_1016_j_jaci_2021_08_006 crossref_primary_10_4103_2221_1691_380562 crossref_primary_10_2217_imt_2015_0027 crossref_primary_10_1007_s00761_015_3002_5 crossref_primary_10_3389_fimmu_2020_02118 crossref_primary_10_1097_ACI_0000000000000858 crossref_primary_10_1080_1744666X_2018_1401469 crossref_primary_10_1016_j_iac_2020_06_008 crossref_primary_10_1002_alr_23221 crossref_primary_10_1007_s40521_018_0177_1 crossref_primary_10_1016_j_aller_2017_09_003 crossref_primary_10_1002_eji_201545869 crossref_primary_10_4168_aair_2018_10_1_18 crossref_primary_10_1080_00365521_2016_1205130 crossref_primary_10_2217_nnm_2016_0111 crossref_primary_10_1016_j_colsurfb_2022_112916 crossref_primary_10_1016_j_jaci_2014_12_1938 crossref_primary_10_1002_alr_23011 crossref_primary_10_1186_s13601_019_0266_7 crossref_primary_10_1183_13993003_00476_2019 crossref_primary_10_1016_j_imlet_2018_01_012 crossref_primary_10_1016_j_jaci_2015_12_1153 crossref_primary_10_1111_all_12832 crossref_primary_10_1183_13993003_00446_2022 crossref_primary_10_1016_j_reval_2015_07_007 crossref_primary_10_3390_ijms252312615 crossref_primary_10_1016_j_smim_2019_101326 crossref_primary_10_1038_cmi_2016_14 crossref_primary_10_2500_aap_2022_43_220033 crossref_primary_10_3389_fimmu_2021_623805 crossref_primary_10_1038_cmi_2015_09 crossref_primary_10_1111_all_12845 crossref_primary_10_14712_18059694_2025_6 crossref_primary_10_1016_j_smim_2017_08_008 crossref_primary_10_1016_j_iac_2015_08_009 crossref_primary_10_1016_j_iac_2015_08_008 crossref_primary_10_1016_j_iac_2015_08_003 crossref_primary_10_1016_j_iac_2015_08_004 crossref_primary_10_1080_14712598_2018_1402003 crossref_primary_10_1111_all_13944 crossref_primary_10_1111_all_12859 crossref_primary_10_1371_journal_pone_0170577 crossref_primary_10_1016_j_humic_2018_10_001 crossref_primary_10_1002_ohn_648 crossref_primary_10_1016_j_ijbiomac_2020_07_325 crossref_primary_10_1038_srep46142 crossref_primary_10_1002_ohn_649 crossref_primary_10_1073_pnas_1520180113 crossref_primary_10_1016_S1877_7848_25_50724_4 crossref_primary_10_1111_all_13396 crossref_primary_10_2500_ajra_2016_30_4367 crossref_primary_10_1016_j_clim_2015_02_016 crossref_primary_10_1007_s11882_016_0650_5 crossref_primary_10_1586_1744666X_2015_1086645 crossref_primary_10_1002_ccr3_4188 crossref_primary_10_1080_1744666X_2019_1649597 crossref_primary_10_2500_ajra_2016_30_4253 crossref_primary_10_1186_s13052_017_0348_x crossref_primary_10_1111_all_16311 crossref_primary_10_1111_all_15107 crossref_primary_10_1016_j_vaccine_2019_09_095 crossref_primary_10_1111_vde_12470 crossref_primary_10_1111_all_14264 crossref_primary_10_1111_all_14265 crossref_primary_10_1016_j_jaut_2021_102634 crossref_primary_10_1016_j_jaci_2015_12_1300 crossref_primary_10_1007_s11882_017_0727_9 crossref_primary_10_1016_j_jaci_2015_10_047 crossref_primary_10_3389_fimmu_2024_1429442 crossref_primary_10_1016_j_prenap_2025_100159 crossref_primary_10_1038_gene_2014_45 crossref_primary_10_1016_j_vetpar_2016_06_019 crossref_primary_10_1016_j_anai_2015_10_002 crossref_primary_10_4168_aair_2022_14_6_604 crossref_primary_10_1111_all_13064 crossref_primary_10_1007_s13671_019_00279_w crossref_primary_10_1097_ACI_0000000000000693 crossref_primary_10_1016_j_intimp_2022_109394 crossref_primary_10_1111_all_15012 crossref_primary_10_1371_journal_pone_0148838 crossref_primary_10_1007_s12016_018_8678_z crossref_primary_10_1172_JCI122631 crossref_primary_10_1111_all_13199 crossref_primary_10_1111_cea_12722 crossref_primary_10_1016_j_molimm_2016_04_005 crossref_primary_10_1016_j_jaci_2015_05_006 crossref_primary_10_1016_j_ebiom_2022_104093 crossref_primary_10_3390_children11060692 crossref_primary_10_3390_ijms26146779 crossref_primary_10_1007_s12016_015_8514_7 crossref_primary_10_1007_s40521_023_00337_6 crossref_primary_10_1097_ACI_0000000000000580 crossref_primary_10_1097_ICL_0000000000000158 crossref_primary_10_1097_ACI_0000000000000480 crossref_primary_10_1016_j_jaci_2018_02_041 crossref_primary_10_1016_j_jaci_2017_08_049 crossref_primary_10_1007_s13671_019_00276_z crossref_primary_10_1016_j_jaip_2020_11_046 crossref_primary_10_3389_fimmu_2023_1241518 crossref_primary_10_1016_j_ebiom_2018_04_001 crossref_primary_10_1159_000375406 crossref_primary_10_2217_imt_2017_0186 crossref_primary_10_1016_j_amjoto_2019_07_010 crossref_primary_10_1016_j_jaci_2016_07_022 crossref_primary_10_1007_s11882_015_0529_x crossref_primary_10_1016_j_intimp_2015_12_004 crossref_primary_10_1016_j_coph_2014_07_003 crossref_primary_10_1016_j_jaci_2021_05_038 crossref_primary_10_3389_fimmu_2018_03034 crossref_primary_10_1097_ACI_0000000000000118 crossref_primary_10_3389_fimmu_2021_747730 crossref_primary_10_1016_j_ebiom_2018_10_003 crossref_primary_10_1016_j_curtheres_2022_100678 crossref_primary_10_1111_imm_12633 crossref_primary_10_1016_j_cellimm_2016_07_008 crossref_primary_10_1016_j_jaci_2016_06_033 crossref_primary_10_1186_s12865_024_00644_w crossref_primary_10_1016_j_reval_2021_01_007 crossref_primary_10_1016_j_iac_2014_09_003 crossref_primary_10_1111_all_14064 crossref_primary_10_1016_j_jaci_2015_05_023 crossref_primary_10_36303_SAGP_2020_1_1_0010 crossref_primary_10_1111_all_16248 crossref_primary_10_3389_fimmu_2021_599296 crossref_primary_10_1016_j_jaci_2018_01_042 crossref_primary_10_1016_j_jaci_2015_05_029 crossref_primary_10_1515_med_2021_0285 crossref_primary_10_1016_j_intimp_2024_111607 crossref_primary_10_1016_j_anai_2023_07_006 crossref_primary_10_1007_s40521_015_0045_1 crossref_primary_10_1007_s15007_018_1688_6 crossref_primary_10_1016_j_jaci_2019_02_008 crossref_primary_10_1038_s41577_023_00871_z crossref_primary_10_1136_gutjnl_2025_335375 crossref_primary_10_1016_j_anpedi_2017_10_014 crossref_primary_10_1186_s12948_017_0070_7 crossref_primary_10_1007_s15007_018_1764_y crossref_primary_10_1016_j_jaci_2017_08_025 |
| Cites_doi | 10.1172/JCI118603 10.1111/j.1398-9995.2005.00699.x 10.1111/j.1398-9995.2008.01774.x 10.1016/j.jaci.2010.11.047 10.1006/cimm.2000.1739 10.1046/j.1365-2222.2003.01567.x 10.1159/000083956 10.1016/j.jaci.2009.10.035 10.1084/jem.192.9.1213 10.1016/0091-6749(82)90062-8 10.1016/j.jaci.2012.05.003 10.1111/all.12133 10.1146/annurev.immunol.24.021605.090737 10.1111/j.1600-065X.1996.tb00906.x 10.1016/j.jaci.2012.04.039 10.1111/j.1365-2222.2011.03794.x 10.3109/02770909509089497 10.1111/j.1398-9995.2011.02583.x 10.1084/jem.20032058 10.1016/0091-6749(88)90021-8 10.4049/jimmunol.172.5.3252 10.1146/annurev-immunol-020711-074934 10.1038/nri1589 10.1034/j.1398-9995.2001.056003231.x 10.1016/j.jaci.2010.11.050 10.1615/CritRevImmunol.2013007046 10.1084/jem.20070590 10.1016/j.jaci.2011.06.051 10.4049/jimmunol.143.4.1310 10.1016/S1081-1206(10)61186-6 10.4049/jimmunol.154.8.4187 10.1007/s11882-996-0005-8 10.1016/j.jaci.2013.02.044 10.1172/JCI107204 10.1002/eji.200425523 10.1002/jcp.21001 10.1159/000095461 10.1016/0091-6749(82)90172-5 10.1016/j.jaci.2012.10.058 10.1038/nature04754 10.1016/j.jaci.2013.02.036 10.1016/j.jaci.2013.07.030 10.1002/1521-4141(200006)30:6<1683::AID-IMMU1683>3.0.CO;2-A 10.1111/j.1398-9995.1989.tb04172.x 10.1016/S0091-6749(97)70084-8 10.1146/annurev.immunol.21.120601.141122 10.1016/j.jaci.2007.04.004 10.1111/all.12180 10.1038/nm.2754 10.1159/000073260 10.1002/eji.200322919 10.2332/allergolint.13-RAI-0608 10.1172/JCI200320274 10.1016/S1286-4579(99)00250-6 10.1016/j.jaci.2011.09.031 10.1038/nm0804-801 10.1111/j.1600-065X.2011.01021.x 10.1001/jama.2013.2049 10.1159/000083320 10.1038/nature10772 10.1038/86302 10.1084/jem.20080193 10.1038/35096564 10.1371/journal.pbio.0050329 10.4049/jimmunol.146.6.1829 10.1111/j.1365-2222.1997.tb01225.x 10.1096/fj.02-1008com 10.1016/j.jaci.2010.12.1080 10.4049/jimmunol.152.9.4368 10.1084/jem.20090596 10.1172/JCI2250 10.1038/nri1032 10.1016/j.jaci.2013.01.049 10.1111/j.1365-2222.1995.tb00007.x 10.1172/JCI118506 10.1016/j.jaci.2007.05.036 10.1038/nri3464 10.1016/S0162-3109(00)00268-X 10.1038/nrd2653 10.1111/j.1365-2222.1989.tb02405.x 10.1084/jem.20021293 10.1111/j.1365-2222.1997.tb00674.x 10.1172/JCI11679 10.1016/j.jaci.2012.10.051 10.1016/j.molimm.2008.07.031 10.1016/0091-6749(88)90017-6 10.1016/j.immuni.2005.01.016 10.1172/JCI200113930 10.1016/j.jaci.2013.01.014 10.1016/j.jaci.2012.02.014 10.1084/jem.20030152 10.1016/j.jaci.2010.11.037 10.4049/jimmunol.181.8.5396 10.1111/j.1398-9995.2006.01206.x 10.1034/j.1398-9995.2003.00193.x 10.1172/JCI112233 10.1067/mai.2003.1570 10.1038/83713 10.1016/j.jaci.2005.06.004 10.1084/jem.20061660 |
| ContentType | Journal Article |
| Copyright | 2014 American Academy of Allergy, Asthma & Immunology American Academy of Allergy, Asthma & Immunology 2015 INIST-CNRS Copyright © 2014 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved. Copyright Elsevier Limited Mar 2014 |
| Copyright_xml | – notice: 2014 American Academy of Allergy, Asthma & Immunology – notice: American Academy of Allergy, Asthma & Immunology – notice: 2015 INIST-CNRS – notice: Copyright © 2014 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved. – notice: Copyright Elsevier Limited Mar 2014 |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7SS 7T5 H94 K9. NAPCQ 7X8 |
| DOI | 10.1016/j.jaci.2013.12.1088 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Entomology Abstracts (Full archive) Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Entomology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Immunology Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Entomology Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1097-6825 |
| EndPage | 631 |
| ExternalDocumentID | 3556035851 24581429 28383866 10_1016_j_jaci_2013_12_1088 S0091674914001067 1_s2_0_S0091674914001067 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Review |
| GrantInformation_xml | – fundername: Swiss National Foundation grantid: 320030_140772 and 320030_132899 – fundername: PREDICTA: Post-Infectious Immune Reprogramming and Its Association with Persistence and Chronicity of Respiratory Allergic Diseases grantid: 260895 – fundername: Swiss National Science Foundation, EF7 MeDALL, and EF7 Predicta – fundername: Novartis, PREDICTA, the Swiss National Science Foundation, MeDALL, and the Christine Kühne Center for Allergy Research and Education Research – fundername: Christine Kühne Center for Allergy Research and Education (CK-CARE) |
| GroupedDBID | --- --K --M -~X .1- .55 .FO .GJ .XZ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 354 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8F7 8FE 8FH 8P~ 9JM AAAJQ AABNK AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABJNI ABLJU ABMAC ABMZM ABOCM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACLOT ACPRK ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFRT ADMUD ADNMO ADVLN ADXHL AEBSH AEIPS AEKER AENEX AEUPX AFFNX AFJKZ AFPUW AFRAH AFRHN AFTJW AFXIZ AGEKW AGHFR AGQPQ AGUBO AGYEJ AHHHB AHMBA AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV BPHCQ BVXVI C45 CAG CJTIS COF CS3 DU5 EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDU HMK HMO HVGLF HZ~ IHE J1W J5H K-O KOM L7B LK8 LUGTX M27 M41 MO0 N4W N9A O-L O9- O9~ OAUVE OBH ODZKP OHH OHT OK0 OK1 OVD OZT P-8 P-9 P2P PC. PQQKQ PROAC Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SJN SPCBC SSH SSI SSZ T5K TEORI TWZ UGJ UNMZH UV1 WH7 WOW WUQ X7M XFW YOC YQI YQJ Z5R ZGI ZXP ZY1 ~02 ~G- ~HD ~KM AACTN RIG 9DU AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7SS 7T5 H94 K9. NAPCQ 7X8 |
| ID | FETCH-LOGICAL-c623t-d03e7c97e37dbcf0306cbd4c4675db0beb9f918c65cdcb92e0fd8f50baa29b083 |
| ISICitedReferencesCount | 439 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000332397600002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0091-6749 1097-6825 |
| IngestDate | Thu Oct 02 10:25:22 EDT 2025 Sat Sep 27 22:53:05 EDT 2025 Tue Oct 07 06:28:36 EDT 2025 Thu Apr 03 07:06:08 EDT 2025 Wed Apr 02 07:35:53 EDT 2025 Sat Nov 29 07:24:53 EST 2025 Tue Nov 18 22:39:53 EST 2025 Sun Apr 06 06:53:40 EDT 2025 Wed Apr 02 07:27:48 EDT 2025 Tue Oct 14 19:30:02 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | VIT PLA IgE IgG eosinophils HR basophils Regulatory T cells T cells mast cells SHP-1 Breg LPR immune tolerance immunotherapy TGF-β CTLA-4 TLR ICOS BR1 SLIT allergen immunotherapy Treg B cells AIT FOXP3 IL-10 pDC TR1 T helper cells PD-1 DC Src homology domain 2–containing protein tyrosine phosphatase 1 Programmed death 1 Forkhead box protein 3 Regulatory T IL-10–secreting regulatory B Histamine receptor Toll-like receptor Dendritic cell B R1 Inducible costimulator IL-10–secreting regulatory T Regulatory B Phospholipase A 2 T R1 Plasmacytoid dendritic cell Cytotoxic T lymphocyte antigen 4 Late-phase response Venom immunotherapy Sublingual immunotherapy Allergen-specific immunotherapy Allergy Transforming growth factor β Granulocyte Helper cell Basophil Mechanism Immunology Immunotherapy T-Lymphocyte Suppressor Regulatory cell Immunopathology Immunoglobulins Desensitization Multiple Cytokine B-Lymphocyte Eosinophil Treatment Immune tolerance Interleukin 10 Mast cell Allergen |
| Language | English |
| License | CC BY 4.0 Copyright © 2014 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c623t-d03e7c97e37dbcf0306cbd4c4675db0beb9f918c65cdcb92e0fd8f50baa29b083 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| PMID | 24581429 |
| PQID | 1644784553 |
| PQPubID | 105664 |
| PageCount | 11 |
| ParticipantIDs | proquest_miscellaneous_1654674883 proquest_miscellaneous_1514438833 proquest_journals_1644784553 pubmed_primary_24581429 pascalfrancis_primary_28383866 crossref_primary_10_1016_j_jaci_2013_12_1088 crossref_citationtrail_10_1016_j_jaci_2013_12_1088 elsevier_sciencedirect_doi_10_1016_j_jaci_2013_12_1088 elsevier_clinicalkeyesjournals_1_s2_0_S0091674914001067 elsevier_clinicalkey_doi_10_1016_j_jaci_2013_12_1088 |
| PublicationCentury | 2000 |
| PublicationDate | 2014-03-01 |
| PublicationDateYYYYMMDD | 2014-03-01 |
| PublicationDate_xml | – month: 03 year: 2014 text: 2014-03-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | New York, NY |
| PublicationPlace_xml | – name: New York, NY – name: United States – name: St. Louis |
| PublicationTitle | Journal of allergy and clinical immunology |
| PublicationTitleAlternate | J Allergy Clin Immunol |
| PublicationYear | 2014 |
| Publisher | Elsevier Inc Elsevier Elsevier Limited |
| Publisher_xml | – name: Elsevier Inc – name: Elsevier – name: Elsevier Limited |
| References | Akdis, Palomares, van de Veen, van Splunter, Akdis (bib14) 2012; 129 Maloy, Powrie (bib64) 2001; 2 Sakaguchi, Vignali, Rudensky, Niec, Waldmann (bib72) 2013; 13 Jutel, Pichler, Skrbic, Urwyler, Dahinden, Müller (bib29) 1995; 154 Sakaguchi (bib71) 2003; 112 Wachholz, Durham (bib40) 2004; 4 Akdis (bib6) 2012; 18 Calderon, Casale, Cox, Akdis, Burks, Nelson (bib2) 2013; 68 Orihara, Narita, Tobe, Akasawa, Ohya, Matsumoto (bib77) 2007; 120 Varney, Edwards, Tabbah, Brewster, Mavroleon, Frew (bib47) 1997; 27 Bousquet, Maasch, Martinot, Hejjaoui, Wahl, Michel (bib38) 1988; 82 Golden, Meyers, Kagey-Sobotka, Valentine, Lichtenstein (bib41) 1982; 69 Zimmer, Bouley, Le Mignon, Pliquet, Horiot, Turfkruyer (bib87) 2012; 129 Mangan, Harrington, O'Quinn, Helms, Bullard, Elson (bib86) 2006; 441 Akdis, Burgler, Crameri, Eiwegger, Fujita, Gomez (bib15) 2011; 127 Hawrylowicz, O'Garra (bib70) 2005; 5 Urry, Xystrakis, Hawrylowicz (bib93) 2006; 6 Novak, Mete, Bussmann, Maintz, Bieber, Akdis (bib22) 2012; 130 Burks, Calderon, Casale, Cox, Demoly, Jutel (bib1) 2013; 131 Taylor, Akdis, Joss, Akkoc, Wenig, Colonna (bib90) 2007; 120 Joss, Akdis, Faith, Blaser, Akdis (bib91) 2000; 30 Jutel, Van de Veen, Agache, Azkur, Akdis, Akdis (bib13) 2013; 62 Mauri, Gray, Mushtaq, Londei (bib61) 2003; 197 van de Veen, Stanic, Yaman, Wawrzyniak, Sollner, Akdis (bib28) 2013; 131 Walker, Durham, Till, Roberts, Corrigan, Leech (bib25) 2011; 41 Akdis (bib7) 2006; 18 Ciprandi, Fenoglio, Cirillo, Vizzaccaro, Ferrera, Tosca (bib103) 2005; 95 Bluestone, Abbas (bib65) 2003; 3 Fontenot, Rasmussen, Williams, Dooley, Farr, Rudensky (bib73) 2005; 22 Schleimer, Derse, Friedman, Gillis, Plaut, Lichtenstein (bib52) 1989; 143 Müller, Helbling, Bischof (bib42) 1989; 44 Akdis, Verhagen, Taylor, Karamloo, Karagiannidis, Crameri (bib31) 2004; 199 Bousquet, Braquemond, Feinberg, Guerin, Maasch, Michel (bib35) 1986; 56 Creticos, Adkinson, Kagey-Sobotka, Proud, Meier, Naclerio (bib49) 1985; 76 Eberlein-Konig, Ullmann, Thomas, Przybilla (bib20) 1995; 25 Savolainen, Jacobsen, Valovirta (bib105) 2006; 61 Van Ree, Van Leeuwen, Dieges, Van Wijk, De Jong, Brewczyski (bib34) 1997; 27 Jutel, Jaeger, Suck, Meyer, Fiebig, Cromwell (bib44) 2005; 116 Platts-Mills, Woodfolk (bib12) 2011; 242 Kucuksezer, Palomares, Ruckert, Jartti, Puhakka, Nandy (bib82) 2013; 131 Francis, Till, Durham (bib32) 2003; 111 Taylor, Verhagen, Akkoc, Wenig, Flory, Blaser (bib92) 2009; 46 Osna, Elliott, Khan (bib98) 2001; 1 Lin, Erekosima, Kim, Ramanathan, Suarez-Cuervo, Chelladurai (bib4) 2013; 309 Plewako, Wosinska, Arvidsson, Bjorkander, Skov, Hakansson (bib21) 2006; 141 Josefowicz, Niec, Kim, Treuting, Chinen, Zheng (bib59) 2012; 482 Mantel, Kuipers, Boyman, Rhyner, Ouaked, Ruckert (bib84) 2007; 5 Marcucci, Sensi, Frati, Bernardini, Novembre, Barbato (bib107) 2003; 58 Sakaguchi (bib68) 2004; 22 Mauri, Bosma (bib33) 2012; 30 Chen, Jin, Hardegen, Lei, Li, Marinos (bib69) 2003; 198 Chen, Liang, Peterson, Munn, Blazar (bib81) 2008; 181 Bennett, Christie, Ramsdell, Brunkow, Ferguson, Whitesell (bib76) 2001; 27 Meiler, Klunker, Zimmermann, Akdis, Akdis (bib26) 2008; 63 Oral, Kotenko, Yilmaz, Mani, Zumkehr, Blaser (bib27) 2006; 36 Hakansson, Heinrich, Rak, Venge (bib48) 1997; 99 Romano, Torres, Castells, Sanz, Blanca (bib19) 2011; 127 Gershon (bib58) 1975; 26 Deniz, van de Veen, Akdis (bib62) 2013; 132 Ito, Yang, Wang, Lande, Gregorio, Perng (bib80) 2007; 204 Palomares, Rückert, Jartti, Kücüksezer, Puhakka, Gomez (bib83) 2012; 129 Meiler, Zumkehr, Klunker, Ruckert, Akdis, Akdis (bib11) 2008; 205 Lichtenstein, Ishizaka, Norman, Sobotka, Hill (bib37) 1973; 52 Radulovic, Wilson, Calderon, Durham (bib101) 2011; 66 Lotvall, Akdis, Bacharier, Bjermer, Casale, Custovic (bib17) 2011; 127 Jonuleit, Schmitt, Schuler, Knop, Enk (bib79) 2000; 192 Zhang, Zhao (bib85) 2007; 211 Jutel, Akdis, Budak, Aebischer-Casaulta, Wrzyszcz, Blaser (bib30) 2003; 33 Coombes, Siddiqui, Arancibia-Carcamo, Hall, Sun, Belkaid (bib78) 2007; 204 Schandane, Alonso-Vega, Willems, Gerard, Delvaux, Velu (bib56) 1994; 152 Ohkawara, Lim, Glibetic, Nakano, Dolovich, Croitoru (bib57) 1996; 97 Akdis, Akdis (bib8) 2013 Jordan, Boesteanu, Reed, Petrone, Holenbeck, Lerman (bib67) 2001; 2 Akdis, Bachert, Cingi, Dykewicz, Hellings, Naclerio (bib18) 2013; 131 Rak, Rowhagen, Venge (bib46) 1988; 82 O'Garra, Vieira (bib66) 2004; 10 Treter, Luqman (bib53) 2000; 206 Rolinck-Werninghaus, Kopp, Liebke, Lange, Wahn, Niggemann (bib104) 2005; 136 Marcucci, Sensi, Migali, Coniglio (bib106) 2001; 56 Flicker, Valenta (bib39) 2003; 132 Nouri-Aria, Wachholz, Francis, Jacobson, Walker, Wilcock (bib43) 2004; 172 Kunzmann, Mantel, Wohlfahrt, Akdis, Blaser, Schmidt-Weber (bib99) 2003; 17 Shim, Kim, Cho, Min, Hong (bib54) 2003; 33 Li, Wan, Sanjabi, Robertson, Flavell (bib88) 2006; 24 Chen, Yu, Wang (bib50) 1995; 32 Van Bever, Stevens (bib45) 1989; 19 Walker, Virchow, Bruijnzeel, Blaser (bib51) 1991; 146 Branton, Kopp (bib89) 1999; 1 Akdis, Blesken, Akdis, Wuthrich, Blaser (bib24) 1998; 102 Klunker, Chong, Mantel, Palomares, Bassin, Ziegler (bib74) 2009; 206 Durham, Emminger, Kapp, Colombo, de Monchy, Rak (bib9) 2010; 125 Bahceciler, Arikan, Taylor, Akdis, Blaser, Barlan (bib102) 2005; 136 Akdis, Akdis (bib10) 2009; 8 James, Shamji, Walker, Wilson, Wachholz, Francis (bib23) 2011; 127 Sackesen, van de Veen, Akdis, Soyer, Zumkehr, Ruckert (bib63) 2013; 68 Del Valle, Gantz (bib95) 1997; 273 Mazzoni, Young, Spitzer, Visintin, Segal (bib97) 2001; 108 Berin, Mayer (bib5) 2013; 131 Strober, Cheng, Zeng, Palathumpat, Dejbakhsh-Jones, Huie (bib60) 1996; 149 Chatila, Blaeser, Ho, Lederman, Voulgaropoulos, Helms (bib75) 2000; 106 Gleich, Zimmermann, Henderson, Yunginger (bib36) 1982; 70 Smarr, Bryce, Miller (bib16) 2013; 33 Marshall, Leal-Berumen, Nielsen, Glibetic, Jordana (bib55) 1996; 97 Jutel, Watanabe, Klunker, Akdis, Thomet, Malolepszy (bib96) 2001; 413 Bae, Choi, Park, Chung, Lee (bib3) 2013; 132 O'Mahony, Akdis, Akdis (bib94) 2011; 128 Wilson, Lima, Durham (bib100) 2005; 60 Akdis (10.1016/j.jaci.2013.12.1088_bib8) 2013 Akdis (10.1016/j.jaci.2013.12.1088_bib31) 2004; 199 Kucuksezer (10.1016/j.jaci.2013.12.1088_bib82) 2013; 131 Fontenot (10.1016/j.jaci.2013.12.1088_bib73) 2005; 22 Ohkawara (10.1016/j.jaci.2013.12.1088_bib57) 1996; 97 O'Mahony (10.1016/j.jaci.2013.12.1088_bib94) 2011; 128 Walker (10.1016/j.jaci.2013.12.1088_bib51) 1991; 146 Jordan (10.1016/j.jaci.2013.12.1088_bib67) 2001; 2 Meiler (10.1016/j.jaci.2013.12.1088_bib11) 2008; 205 Jutel (10.1016/j.jaci.2013.12.1088_bib30) 2003; 33 Creticos (10.1016/j.jaci.2013.12.1088_bib49) 1985; 76 Akdis (10.1016/j.jaci.2013.12.1088_bib24) 1998; 102 van de Veen (10.1016/j.jaci.2013.12.1088_bib28) 2013; 131 Klunker (10.1016/j.jaci.2013.12.1088_bib74) 2009; 206 Chen (10.1016/j.jaci.2013.12.1088_bib81) 2008; 181 Lichtenstein (10.1016/j.jaci.2013.12.1088_bib37) 1973; 52 Marcucci (10.1016/j.jaci.2013.12.1088_bib107) 2003; 58 Coombes (10.1016/j.jaci.2013.12.1088_bib78) 2007; 204 Chen (10.1016/j.jaci.2013.12.1088_bib69) 2003; 198 Wachholz (10.1016/j.jaci.2013.12.1088_bib40) 2004; 4 Mauri (10.1016/j.jaci.2013.12.1088_bib61) 2003; 197 Wilson (10.1016/j.jaci.2013.12.1088_bib100) 2005; 60 Joss (10.1016/j.jaci.2013.12.1088_bib91) 2000; 30 Hakansson (10.1016/j.jaci.2013.12.1088_bib48) 1997; 99 Zhang (10.1016/j.jaci.2013.12.1088_bib85) 2007; 211 Shim (10.1016/j.jaci.2013.12.1088_bib54) 2003; 33 Josefowicz (10.1016/j.jaci.2013.12.1088_bib59) 2012; 482 Ciprandi (10.1016/j.jaci.2013.12.1088_bib103) 2005; 95 Mauri (10.1016/j.jaci.2013.12.1088_bib33) 2012; 30 Strober (10.1016/j.jaci.2013.12.1088_bib60) 1996; 149 Kunzmann (10.1016/j.jaci.2013.12.1088_bib99) 2003; 17 Nouri-Aria (10.1016/j.jaci.2013.12.1088_bib43) 2004; 172 Schandane (10.1016/j.jaci.2013.12.1088_bib56) 1994; 152 Urry (10.1016/j.jaci.2013.12.1088_bib93) 2006; 6 Berin (10.1016/j.jaci.2013.12.1088_bib5) 2013; 131 Mantel (10.1016/j.jaci.2013.12.1088_bib84) 2007; 5 Jutel (10.1016/j.jaci.2013.12.1088_bib44) 2005; 116 Bennett (10.1016/j.jaci.2013.12.1088_bib76) 2001; 27 Mangan (10.1016/j.jaci.2013.12.1088_bib86) 2006; 441 Orihara (10.1016/j.jaci.2013.12.1088_bib77) 2007; 120 Sakaguchi (10.1016/j.jaci.2013.12.1088_bib71) 2003; 112 Ito (10.1016/j.jaci.2013.12.1088_bib80) 2007; 204 Plewako (10.1016/j.jaci.2013.12.1088_bib21) 2006; 141 Bluestone (10.1016/j.jaci.2013.12.1088_bib65) 2003; 3 Marshall (10.1016/j.jaci.2013.12.1088_bib55) 1996; 97 Jutel (10.1016/j.jaci.2013.12.1088_bib96) 2001; 413 Bahceciler (10.1016/j.jaci.2013.12.1088_bib102) 2005; 136 Li (10.1016/j.jaci.2013.12.1088_bib88) 2006; 24 Savolainen (10.1016/j.jaci.2013.12.1088_bib105) 2006; 61 Oral (10.1016/j.jaci.2013.12.1088_bib27) 2006; 36 Durham (10.1016/j.jaci.2013.12.1088_bib9) 2010; 125 Eberlein-Konig (10.1016/j.jaci.2013.12.1088_bib20) 1995; 25 Akdis (10.1016/j.jaci.2013.12.1088_bib15) 2011; 127 Platts-Mills (10.1016/j.jaci.2013.12.1088_bib12) 2011; 242 Akdis (10.1016/j.jaci.2013.12.1088_bib7) 2006; 18 Francis (10.1016/j.jaci.2013.12.1088_bib32) 2003; 111 Bae (10.1016/j.jaci.2013.12.1088_bib3) 2013; 132 O'Garra (10.1016/j.jaci.2013.12.1088_bib66) 2004; 10 Akdis (10.1016/j.jaci.2013.12.1088_bib10) 2009; 8 Akdis (10.1016/j.jaci.2013.12.1088_bib18) 2013; 131 Jutel (10.1016/j.jaci.2013.12.1088_bib13) 2013; 62 Smarr (10.1016/j.jaci.2013.12.1088_bib16) 2013; 33 Bousquet (10.1016/j.jaci.2013.12.1088_bib38) 1988; 82 Varney (10.1016/j.jaci.2013.12.1088_bib47) 1997; 27 Jonuleit (10.1016/j.jaci.2013.12.1088_bib79) 2000; 192 Treter (10.1016/j.jaci.2013.12.1088_bib53) 2000; 206 Bousquet (10.1016/j.jaci.2013.12.1088_bib35) 1986; 56 Chatila (10.1016/j.jaci.2013.12.1088_bib75) 2000; 106 Flicker (10.1016/j.jaci.2013.12.1088_bib39) 2003; 132 Radulovic (10.1016/j.jaci.2013.12.1088_bib101) 2011; 66 Rolinck-Werninghaus (10.1016/j.jaci.2013.12.1088_bib104) 2005; 136 Gershon (10.1016/j.jaci.2013.12.1088_bib58) 1975; 26 Gleich (10.1016/j.jaci.2013.12.1088_bib36) 1982; 70 Deniz (10.1016/j.jaci.2013.12.1088_bib62) 2013; 132 Hawrylowicz (10.1016/j.jaci.2013.12.1088_bib70) 2005; 5 Walker (10.1016/j.jaci.2013.12.1088_bib25) 2011; 41 Golden (10.1016/j.jaci.2013.12.1088_bib41) 1982; 69 Novak (10.1016/j.jaci.2013.12.1088_bib22) 2012; 130 Schleimer (10.1016/j.jaci.2013.12.1088_bib52) 1989; 143 Akdis (10.1016/j.jaci.2013.12.1088_bib14) 2012; 129 Romano (10.1016/j.jaci.2013.12.1088_bib19) 2011; 127 Burks (10.1016/j.jaci.2013.12.1088_bib1) 2013; 131 Calderon (10.1016/j.jaci.2013.12.1088_bib2) 2013; 68 Branton (10.1016/j.jaci.2013.12.1088_bib89) 1999; 1 Osna (10.1016/j.jaci.2013.12.1088_bib98) 2001; 1 Meiler (10.1016/j.jaci.2013.12.1088_bib26) 2008; 63 Rak (10.1016/j.jaci.2013.12.1088_bib46) 1988; 82 Lin (10.1016/j.jaci.2013.12.1088_bib4) 2013; 309 Akdis (10.1016/j.jaci.2013.12.1088_bib6) 2012; 18 Sackesen (10.1016/j.jaci.2013.12.1088_bib63) 2013; 68 James (10.1016/j.jaci.2013.12.1088_bib23) 2011; 127 Taylor (10.1016/j.jaci.2013.12.1088_bib90) 2007; 120 Sakaguchi (10.1016/j.jaci.2013.12.1088_bib72) 2013; 13 Chen (10.1016/j.jaci.2013.12.1088_bib50) 1995; 32 Sakaguchi (10.1016/j.jaci.2013.12.1088_bib68) 2004; 22 Van Ree (10.1016/j.jaci.2013.12.1088_bib34) 1997; 27 Zimmer (10.1016/j.jaci.2013.12.1088_bib87) 2012; 129 Marcucci (10.1016/j.jaci.2013.12.1088_bib106) 2001; 56 Lotvall (10.1016/j.jaci.2013.12.1088_bib17) 2011; 127 Van Bever (10.1016/j.jaci.2013.12.1088_bib45) 1989; 19 Palomares (10.1016/j.jaci.2013.12.1088_bib83) 2012; 129 Maloy (10.1016/j.jaci.2013.12.1088_bib64) 2001; 2 Müller (10.1016/j.jaci.2013.12.1088_bib42) 1989; 44 Taylor (10.1016/j.jaci.2013.12.1088_bib92) 2009; 46 Del Valle (10.1016/j.jaci.2013.12.1088_bib95) 1997; 273 Jutel (10.1016/j.jaci.2013.12.1088_bib29) 1995; 154 Mazzoni (10.1016/j.jaci.2013.12.1088_bib97) 2001; 108 |
| References_xml | – volume: 125 start-page: 131 year: 2010 end-page: 138 ident: bib9 article-title: Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet publication-title: J Allergy Clin Immunol – volume: 116 start-page: 608 year: 2005 end-page: 613 ident: bib44 article-title: Allergen-specific immunotherapy with recombinant grass pollen allergens publication-title: J Allergy Clin Immunol – volume: 136 start-page: 287 year: 2005 end-page: 294 ident: bib102 article-title: Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites publication-title: Int Arch Allergy Immunol – volume: 112 start-page: 1310 year: 2003 end-page: 1312 ident: bib71 article-title: The origin of FOXP3-expressing CD4+ regulatory T cells: thymus or periphery publication-title: J Clin Invest – volume: 129 start-page: 510 year: 2012 end-page: 520 ident: bib83 article-title: Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance publication-title: J Allergy Clin Immunol – volume: 211 start-page: 590 year: 2007 end-page: 597 ident: bib85 article-title: The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road publication-title: J Cell Physiol – volume: 146 start-page: 1829 year: 1991 end-page: 1835 ident: bib51 article-title: T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma publication-title: J Immunol – volume: 58 start-page: 657 year: 2003 end-page: 662 ident: bib107 article-title: Effects on inflammation parameters of a double-blind, placebo controlled one-year course of SLIT in children monosensitized to mites publication-title: Allergy – volume: 70 start-page: 261 year: 1982 end-page: 271 ident: bib36 article-title: Effect of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: a six-year prospective study publication-title: J Allergy Clin Immunol – volume: 128 start-page: 1153 year: 2011 end-page: 1162 ident: bib94 article-title: Regulation of the immune response and inflammation by histamine and histamine receptors publication-title: J Allergy Clin Immunol – volume: 27 start-page: 860 year: 1997 end-page: 867 ident: bib47 article-title: Clinical efficacy of specific immunotherapy to cat dander: a double-blind placebo-controlled trial publication-title: Clin Exp Allergy – volume: 8 start-page: 645 year: 2009 end-page: 660 ident: bib10 article-title: Therapeutic manipulation of immune tolerance in allergic disease publication-title: Nat Rev Drug Discov – volume: 82 start-page: 439 year: 1988 end-page: 446 ident: bib38 article-title: Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy publication-title: J Allergy Clin Immunol – volume: 199 start-page: 1567 year: 2004 end-page: 1575 ident: bib31 article-title: Immune responses in healthy and allergic Individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells publication-title: J Exp Med – volume: 22 start-page: 531 year: 2004 end-page: 562 ident: bib68 article-title: Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses publication-title: Annu Rev Immunol – volume: 172 start-page: 3252 year: 2004 end-page: 3259 ident: bib43 article-title: Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity publication-title: J Immunol – volume: 111 start-page: 1255 year: 2003 end-page: 1261 ident: bib32 article-title: Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy publication-title: J Allergy Clin Immunol – volume: 131 start-page: 14 year: 2013 end-page: 22 ident: bib5 article-title: Can we produce true tolerance in patients with food allergy? publication-title: J Allergy Clin Immunol – volume: 76 start-page: 2247 year: 1985 end-page: 2253 ident: bib49 article-title: Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy publication-title: J Clin Invest – volume: 482 start-page: 395 year: 2012 end-page: 399 ident: bib59 article-title: Extrathymically generated regulatory T cells control mucosal TH2 inflammation publication-title: Nature – volume: 197 start-page: 489 year: 2003 end-page: 501 ident: bib61 article-title: Prevention of arthritis by interleukin 10-producing B cells publication-title: J Exp Med – volume: 13 start-page: 461 year: 2013 end-page: 467 ident: bib72 article-title: The plasticity and stability of regulatory T cells publication-title: Nat Rev Immunol – volume: 63 start-page: 1455 year: 2008 end-page: 1463 ident: bib26 article-title: Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors publication-title: Allergy – volume: 204 start-page: 105 year: 2007 end-page: 115 ident: bib80 article-title: Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand publication-title: J Exp Med – volume: 46 start-page: 622 year: 2009 end-page: 629 ident: bib92 article-title: IL-10 suppresses CD2-mediated T cell activation via SHP-1 publication-title: Mol Immunol – volume: 99 start-page: 551 year: 1997 end-page: 562 ident: bib48 article-title: Priming of eosinophil adhesion in patients with birch pollen allergy during pollen season: effect of immunotherapy publication-title: J Allergy Clin Immunol – volume: 44 start-page: 412 year: 1989 end-page: 418 ident: bib42 article-title: Predictive value of venom-specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom publication-title: Allergy – volume: 192 start-page: 1213 year: 2000 end-page: 1222 ident: bib79 article-title: Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells publication-title: J Exp Med – volume: 95 start-page: 38 year: 2005 end-page: 44 ident: bib103 article-title: Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report publication-title: Ann Allergy Asthma Immunol – volume: 205 start-page: 2887 year: 2008 end-page: 2898 ident: bib11 article-title: In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure publication-title: J Exp Med – volume: 97 start-page: 1122 year: 1996 end-page: 1128 ident: bib55 article-title: Interleukin (IL)-10 Inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells publication-title: J Clin Invest – volume: 129 start-page: 1020 year: 2012 end-page: 1030 ident: bib87 article-title: A regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapy publication-title: J Allergy Clin Immunol – volume: 131 start-page: 1479 year: 2013 end-page: 1490 ident: bib18 article-title: Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology publication-title: J Allergy Clin Immunol – volume: 273 start-page: G987 year: 1997 end-page: G996 ident: bib95 article-title: Novel insights into histamine H2 receptor biology publication-title: Am J Physiol – volume: 120 start-page: 76 year: 2007 end-page: 83 ident: bib90 article-title: IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1 publication-title: J Allergy Clin Immunol – volume: 3 start-page: 253 year: 2003 end-page: 257 ident: bib65 article-title: Natural versus adaptive regulatory T cells publication-title: Nat Rev Immunol – volume: 52 start-page: 472 year: 1973 end-page: 482 ident: bib37 article-title: IgE antibody measurements in ragweed hay fever. Relationship to clinical severity and the results of immunotherapy publication-title: J Clin Invest – volume: 4 start-page: 313 year: 2004 end-page: 318 ident: bib40 article-title: Mechanisms of immunotherapy: IgG revisited publication-title: Curr Opin Allergy Clin Immunol – volume: 5 start-page: 271 year: 2005 end-page: 283 ident: bib70 article-title: Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma publication-title: Nat Rev Immunol – volume: 131 start-page: 875 year: 2013 end-page: 885.e9 ident: bib82 article-title: Triggering of specific Toll-like receptors and proinflammatory cytokines breaks allergen-specific T-cell tolerance in human tonsils and peripheral blood publication-title: J Allergy Clin Immunol – volume: 441 start-page: 231 year: 2006 end-page: 234 ident: bib86 article-title: Transforming growth factor-beta induces development of the T(H)17 lineage publication-title: Nature – volume: 242 start-page: 51 year: 2011 end-page: 68 ident: bib12 article-title: Allergens and their role in the allergic immune response publication-title: Immunol Rev – volume: 2 start-page: 301 year: 2001 end-page: 306 ident: bib67 article-title: Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide publication-title: Nat Immunol – year: 2013 ident: bib8 article-title: Immune tolerance publication-title: Middleton’s allergy: principles and practice – volume: 152 start-page: 4368 year: 1994 end-page: 4374 ident: bib56 article-title: B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10 publication-title: J Immunol – volume: 198 start-page: 1875 year: 2003 end-page: 1886 ident: bib69 article-title: Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 publication-title: J Exp Med – volume: 206 start-page: 2701 year: 2009 end-page: 2715 ident: bib74 article-title: Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells publication-title: J Exp Med – volume: 41 start-page: 1177 year: 2011 end-page: 1200 ident: bib25 article-title: Immunotherapy for allergic rhinitis publication-title: Clin Exp Allergy – volume: 309 start-page: 1278 year: 2013 end-page: 1288 ident: bib4 article-title: Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review publication-title: JAMA – volume: 102 start-page: 98 year: 1998 end-page: 106 ident: bib24 article-title: Role of interleukin 10 in specific immunotherapy publication-title: J Clin Invest – volume: 27 start-page: 20 year: 2001 end-page: 21 ident: bib76 article-title: The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 publication-title: Nat Genet – volume: 17 start-page: 1089 year: 2003 end-page: 1095 ident: bib99 article-title: Histamine enhances TGF-beta1-mediated suppression of Th2 responses publication-title: FASEB J – volume: 60 start-page: 4 year: 2005 end-page: 12 ident: bib100 article-title: Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis publication-title: Allergy – volume: 25 start-page: 704 year: 1995 end-page: 712 ident: bib20 article-title: Tryptase and histamine release due to a sting challenge in bee venom allergic patients treated successfully or unsuccessfully with hyposensitization publication-title: Clin Exp Allergy – volume: 56 start-page: 456 year: 1986 end-page: 459 ident: bib35 article-title: Specific IgE response with a standardized allergen or allergoid in grass pollen allergy publication-title: Ann Allergy – volume: 33 start-page: 52 year: 2003 end-page: 57 ident: bib54 article-title: Allergen-specific conventional immunotherapy decreases immunoglobulin E-mediated basophil histamine releasability publication-title: Clin Exp Allergy – volume: 30 start-page: 221 year: 2012 end-page: 241 ident: bib33 article-title: Immune regulatory function of B cells publication-title: Annu Rev Immunol – volume: 36 start-page: 380 year: 2006 end-page: 388 ident: bib27 article-title: Regulation of T cells and cytokines by the interleukin-10 (IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26 publication-title: Eur J Immunol – volume: 127 start-page: S67 year: 2011 end-page: S73 ident: bib19 article-title: Diagnosis and management of drug hypersensitivity reactions publication-title: J Allergy Clin Immunol – volume: 33 start-page: 1205 year: 2003 end-page: 1214 ident: bib30 article-title: IL-10 and TGF-b cooperate in regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy publication-title: Eur J Immunol – volume: 5 start-page: e329 year: 2007 ident: bib84 article-title: GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells publication-title: PLoS Biol – volume: 181 start-page: 5396 year: 2008 end-page: 5404 ident: bib81 article-title: The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation publication-title: J Immunol – volume: 18 start-page: 736 year: 2012 end-page: 749 ident: bib6 article-title: Therapies for allergic inflammation: refining strategies to induce tolerance publication-title: Nat Med – volume: 61 start-page: 1184 year: 2006 end-page: 1190 ident: bib105 article-title: Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC publication-title: Allergy – volume: 56 start-page: 231 year: 2001 end-page: 236 ident: bib106 article-title: Eosinophil cationic protein and specific IgE in serum and nasal mucosa of patients with grass-pollen-allergic rhinitis and asthma publication-title: Allergy – volume: 22 start-page: 329 year: 2005 end-page: 341 ident: bib73 article-title: Regulatory T cell lineage specification by the forkhead transcription factor foxp3 publication-title: Immunity – volume: 127 start-page: 701 year: 2011 end-page: 721 ident: bib15 article-title: Interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases publication-title: J Allergy Clin Immunol – volume: 66 start-page: 740 year: 2011 end-page: 752 ident: bib101 article-title: Systematic reviews of sublingual immunotherapy (SLIT) publication-title: Allergy – volume: 143 start-page: 1310 year: 1989 end-page: 1327 ident: bib52 article-title: Regulation of human basophil mediator release by cytokines. I. Interaction with anti-inflammatory steroids publication-title: J Immunol – volume: 120 start-page: 960 year: 2007 end-page: 962 ident: bib77 article-title: Circulating Foxp3+CD4+ cell numbers in atopic patients and healthy control subjects publication-title: J Allergy Clin Immunol – volume: 10 start-page: 801 year: 2004 end-page: 805 ident: bib66 article-title: Regulatory T cells and mechanisms of immune system control publication-title: Nat Med – volume: 129 start-page: 1438 year: 2012 end-page: 1451 ident: bib14 article-title: TH17 and TH22 cells: a confusion of antimicrobial response with tissue inflammation versus protection publication-title: J Allergy Clin Immunol – volume: 6 start-page: 363 year: 2006 end-page: 371 ident: bib93 article-title: Interleukin-10-secreting regulatory T cells in allergy and asthma publication-title: Curr Allergy Asthma Rep – volume: 127 start-page: 355 year: 2011 end-page: 360 ident: bib17 article-title: Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome publication-title: J Allergy Clin Immunol – volume: 1 start-page: 1349 year: 1999 end-page: 1365 ident: bib89 article-title: TGF-beta and fibrosis publication-title: Microbes Infect – volume: 97 start-page: 1761 year: 1996 end-page: 1766 ident: bib57 article-title: CD40 expression by human peripheral blood eosinophils publication-title: J Clin Invest – volume: 33 start-page: 389 year: 2013 end-page: 414 ident: bib16 article-title: Antigen-specific tolerance in immunotherapy of Th2-associated allergic diseases publication-title: Crit Rev Immunol – volume: 18 start-page: 718 year: 2006 end-page: 726 ident: bib7 article-title: Allergy and hypersensitivity: mechanisms of allergic disease publication-title: Curr Opin Immunol – volume: 141 start-page: 346 year: 2006 end-page: 353 ident: bib21 article-title: Basophil interleukin 4 and interleukin 13 production is suppressed during the early phase of rush immunotherapy publication-title: Int Arch Allergy Immunol – volume: 19 start-page: 399 year: 1989 end-page: 404 ident: bib45 article-title: Suppression of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite publication-title: Clin Exp Allergy – volume: 108 start-page: 1865 year: 2001 end-page: 1873 ident: bib97 article-title: Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization publication-title: J Clin Invest – volume: 206 start-page: 116 year: 2000 end-page: 124 ident: bib53 article-title: Antigen-specific T cell tolerance down-regulates mast cell responses in vivo publication-title: Cell Immunol – volume: 130 start-page: 1153 year: 2012 end-page: 1158 ident: bib22 article-title: Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2 publication-title: J Allergy Clin Immunol – volume: 413 start-page: 420 year: 2001 end-page: 425 ident: bib96 article-title: Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors publication-title: Nature – volume: 131 start-page: 1288 year: 2013 end-page: 1296.e3 ident: bib1 article-title: Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report publication-title: J Allergy Clin Immunol – volume: 69 start-page: 489 year: 1982 end-page: 493 ident: bib41 article-title: Clinical relevance of the venom-specific immunoglobulin G antibody level during immunotherapy publication-title: J Allergy Clin Immunol – volume: 131 start-page: 1204 year: 2013 end-page: 1212 ident: bib28 article-title: IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses publication-title: J Allergy Clin Immunol – volume: 26 start-page: 170 year: 1975 end-page: 185 ident: bib58 article-title: A disquisition on suppressor T cells publication-title: Transplant Rev – volume: 62 start-page: 425 year: 2013 end-page: 433 ident: bib13 article-title: Mechanisms of allergen-specific immunotherapy and novel ways for vaccine development publication-title: Allergol Int – volume: 132 start-page: 527 year: 2013 end-page: 535 ident: bib62 article-title: Natural killer cells in patients with allergic diseases publication-title: J Allergy Clin Immunol – volume: 2 start-page: 816 year: 2001 end-page: 822 ident: bib64 article-title: Regulatory T cells in the control of immune pathology publication-title: Nat Immunol – volume: 106 start-page: R75 year: 2000 end-page: R81 ident: bib75 article-title: JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome publication-title: J Clin Invest – volume: 127 start-page: 509 year: 2011 end-page: 516 ident: bib23 article-title: Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies publication-title: J Allergy Clin Immunol – volume: 132 start-page: 13 year: 2003 end-page: 24 ident: bib39 article-title: Renaissance of the blocking antibody concept in type I allergy publication-title: Int Arch Allergy Immunol – volume: 68 start-page: 593 year: 2013 end-page: 603 ident: bib63 article-title: Suppression of B-cell activation and IgE, IgA, IgG1 and IgG4 production by mammalian telomeric oligonucleotides publication-title: Allergy – volume: 32 start-page: 29 year: 1995 end-page: 35 ident: bib50 article-title: Decreased production of endothelin-1 in asthmatic children after immunotherapy publication-title: J Asthma – volume: 68 start-page: 825 year: 2013 end-page: 828 ident: bib2 article-title: Allergen immunotherapy: a new semantic framework from the European Academy of Allergy and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL consensus report publication-title: Allergy – volume: 132 start-page: 110 year: 2013 end-page: 117 ident: bib3 article-title: Efficacy of allergen-specific immunotherapy for atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials publication-title: J Allergy Clin Immunol – volume: 27 start-page: 68 year: 1997 end-page: 74 ident: bib34 article-title: Measurement of IgE antibodies against purified grass pollen allergens (Lol p 1, 2, 3 and 5) during immunotherapy publication-title: Clin Exp Allergy – volume: 136 start-page: 134 year: 2005 end-page: 141 ident: bib104 article-title: Lack of detectable alterations in immune responses during sublingual immunotherapy in children with seasonal allergic rhinoconjunctivitis to grass pollen publication-title: Int Arch Allergy Immunol – volume: 154 start-page: 4178 year: 1995 end-page: 4194 ident: bib29 article-title: Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-g secretion in specific allergen stimulated T cell cultures publication-title: J Immunol – volume: 149 start-page: 217 year: 1996 end-page: 230 ident: bib60 article-title: Double negative (CD4-CD8- alpha beta+) T cells which promote tolerance induction and regulate autoimmunity publication-title: Immunol Rev – volume: 82 start-page: 470 year: 1988 end-page: 480 ident: bib46 article-title: The effect of immunotherapy on bronchial hyper-responsiveness and eosinophil cationic protein in pollen allergic patients publication-title: J Allergy Clin Immunol – volume: 24 start-page: 99 year: 2006 end-page: 146 ident: bib88 article-title: Transforming growth factor-beta regulation of immune responses publication-title: Annu Rev Immunol – volume: 1 start-page: 85 year: 2001 end-page: 96 ident: bib98 article-title: Regulation of interleukin-10 secretion by histamine in TH2 cells and splenocytes publication-title: Int Immunopharmacol – volume: 204 start-page: 1757 year: 2007 end-page: 1764 ident: bib78 article-title: A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism publication-title: J Exp Med – volume: 30 start-page: 1683 year: 2000 end-page: 1690 ident: bib91 article-title: IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway publication-title: Eur J Immunol – volume: 97 start-page: 1761 year: 1996 ident: 10.1016/j.jaci.2013.12.1088_bib57 article-title: CD40 expression by human peripheral blood eosinophils publication-title: J Clin Invest doi: 10.1172/JCI118603 – volume: 60 start-page: 4 year: 2005 ident: 10.1016/j.jaci.2013.12.1088_bib100 article-title: Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis publication-title: Allergy doi: 10.1111/j.1398-9995.2005.00699.x – volume: 63 start-page: 1455 year: 2008 ident: 10.1016/j.jaci.2013.12.1088_bib26 article-title: Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors publication-title: Allergy doi: 10.1111/j.1398-9995.2008.01774.x – volume: 127 start-page: S67 issue: Suppl year: 2011 ident: 10.1016/j.jaci.2013.12.1088_bib19 article-title: Diagnosis and management of drug hypersensitivity reactions publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2010.11.047 – volume: 206 start-page: 116 year: 2000 ident: 10.1016/j.jaci.2013.12.1088_bib53 article-title: Antigen-specific T cell tolerance down-regulates mast cell responses in vivo publication-title: Cell Immunol doi: 10.1006/cimm.2000.1739 – volume: 33 start-page: 52 year: 2003 ident: 10.1016/j.jaci.2013.12.1088_bib54 article-title: Allergen-specific conventional immunotherapy decreases immunoglobulin E-mediated basophil histamine releasability publication-title: Clin Exp Allergy doi: 10.1046/j.1365-2222.2003.01567.x – volume: 136 start-page: 287 year: 2005 ident: 10.1016/j.jaci.2013.12.1088_bib102 article-title: Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites publication-title: Int Arch Allergy Immunol doi: 10.1159/000083956 – volume: 125 start-page: 131 year: 2010 ident: 10.1016/j.jaci.2013.12.1088_bib9 article-title: Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2009.10.035 – volume: 192 start-page: 1213 year: 2000 ident: 10.1016/j.jaci.2013.12.1088_bib79 article-title: Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells publication-title: J Exp Med doi: 10.1084/jem.192.9.1213 – volume: 70 start-page: 261 year: 1982 ident: 10.1016/j.jaci.2013.12.1088_bib36 article-title: Effect of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: a six-year prospective study publication-title: J Allergy Clin Immunol doi: 10.1016/0091-6749(82)90062-8 – volume: 129 start-page: 1438 year: 2012 ident: 10.1016/j.jaci.2013.12.1088_bib14 article-title: TH17 and TH22 cells: a confusion of antimicrobial response with tissue inflammation versus protection publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2012.05.003 – volume: 68 start-page: 593 year: 2013 ident: 10.1016/j.jaci.2013.12.1088_bib63 article-title: Suppression of B-cell activation and IgE, IgA, IgG1 and IgG4 production by mammalian telomeric oligonucleotides publication-title: Allergy doi: 10.1111/all.12133 – volume: 24 start-page: 99 year: 2006 ident: 10.1016/j.jaci.2013.12.1088_bib88 article-title: Transforming growth factor-beta regulation of immune responses publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.24.021605.090737 – volume: 149 start-page: 217 year: 1996 ident: 10.1016/j.jaci.2013.12.1088_bib60 article-title: Double negative (CD4-CD8- alpha beta+) T cells which promote tolerance induction and regulate autoimmunity publication-title: Immunol Rev doi: 10.1111/j.1600-065X.1996.tb00906.x – volume: 130 start-page: 1153 year: 2012 ident: 10.1016/j.jaci.2013.12.1088_bib22 article-title: Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2 publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2012.04.039 – volume: 41 start-page: 1177 year: 2011 ident: 10.1016/j.jaci.2013.12.1088_bib25 article-title: Immunotherapy for allergic rhinitis publication-title: Clin Exp Allergy doi: 10.1111/j.1365-2222.2011.03794.x – volume: 32 start-page: 29 year: 1995 ident: 10.1016/j.jaci.2013.12.1088_bib50 article-title: Decreased production of endothelin-1 in asthmatic children after immunotherapy publication-title: J Asthma doi: 10.3109/02770909509089497 – volume: 66 start-page: 740 year: 2011 ident: 10.1016/j.jaci.2013.12.1088_bib101 article-title: Systematic reviews of sublingual immunotherapy (SLIT) publication-title: Allergy doi: 10.1111/j.1398-9995.2011.02583.x – volume: 199 start-page: 1567 year: 2004 ident: 10.1016/j.jaci.2013.12.1088_bib31 article-title: Immune responses in healthy and allergic Individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells publication-title: J Exp Med doi: 10.1084/jem.20032058 – volume: 82 start-page: 470 year: 1988 ident: 10.1016/j.jaci.2013.12.1088_bib46 article-title: The effect of immunotherapy on bronchial hyper-responsiveness and eosinophil cationic protein in pollen allergic patients publication-title: J Allergy Clin Immunol doi: 10.1016/0091-6749(88)90021-8 – volume: 273 start-page: G987 year: 1997 ident: 10.1016/j.jaci.2013.12.1088_bib95 article-title: Novel insights into histamine H2 receptor biology publication-title: Am J Physiol – volume: 172 start-page: 3252 year: 2004 ident: 10.1016/j.jaci.2013.12.1088_bib43 article-title: Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity publication-title: J Immunol doi: 10.4049/jimmunol.172.5.3252 – volume: 30 start-page: 221 year: 2012 ident: 10.1016/j.jaci.2013.12.1088_bib33 article-title: Immune regulatory function of B cells publication-title: Annu Rev Immunol doi: 10.1146/annurev-immunol-020711-074934 – volume: 5 start-page: 271 year: 2005 ident: 10.1016/j.jaci.2013.12.1088_bib70 article-title: Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma publication-title: Nat Rev Immunol doi: 10.1038/nri1589 – volume: 2 start-page: 816 year: 2001 ident: 10.1016/j.jaci.2013.12.1088_bib64 article-title: Regulatory T cells in the control of immune pathology publication-title: Nat Immunol – volume: 26 start-page: 170 year: 1975 ident: 10.1016/j.jaci.2013.12.1088_bib58 article-title: A disquisition on suppressor T cells publication-title: Transplant Rev – volume: 56 start-page: 231 year: 2001 ident: 10.1016/j.jaci.2013.12.1088_bib106 article-title: Eosinophil cationic protein and specific IgE in serum and nasal mucosa of patients with grass-pollen-allergic rhinitis and asthma publication-title: Allergy doi: 10.1034/j.1398-9995.2001.056003231.x – volume: 127 start-page: 701 year: 2011 ident: 10.1016/j.jaci.2013.12.1088_bib15 article-title: Interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2010.11.050 – volume: 33 start-page: 389 year: 2013 ident: 10.1016/j.jaci.2013.12.1088_bib16 article-title: Antigen-specific tolerance in immunotherapy of Th2-associated allergic diseases publication-title: Crit Rev Immunol doi: 10.1615/CritRevImmunol.2013007046 – volume: 204 start-page: 1757 year: 2007 ident: 10.1016/j.jaci.2013.12.1088_bib78 article-title: A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism publication-title: J Exp Med doi: 10.1084/jem.20070590 – volume: 128 start-page: 1153 year: 2011 ident: 10.1016/j.jaci.2013.12.1088_bib94 article-title: Regulation of the immune response and inflammation by histamine and histamine receptors publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2011.06.051 – volume: 143 start-page: 1310 year: 1989 ident: 10.1016/j.jaci.2013.12.1088_bib52 article-title: Regulation of human basophil mediator release by cytokines. I. Interaction with anti-inflammatory steroids publication-title: J Immunol doi: 10.4049/jimmunol.143.4.1310 – volume: 95 start-page: 38 year: 2005 ident: 10.1016/j.jaci.2013.12.1088_bib103 article-title: Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report publication-title: Ann Allergy Asthma Immunol doi: 10.1016/S1081-1206(10)61186-6 – volume: 154 start-page: 4178 year: 1995 ident: 10.1016/j.jaci.2013.12.1088_bib29 article-title: Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-g secretion in specific allergen stimulated T cell cultures publication-title: J Immunol doi: 10.4049/jimmunol.154.8.4187 – volume: 6 start-page: 363 year: 2006 ident: 10.1016/j.jaci.2013.12.1088_bib93 article-title: Interleukin-10-secreting regulatory T cells in allergy and asthma publication-title: Curr Allergy Asthma Rep doi: 10.1007/s11882-996-0005-8 – volume: 132 start-page: 110 year: 2013 ident: 10.1016/j.jaci.2013.12.1088_bib3 article-title: Efficacy of allergen-specific immunotherapy for atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2013.02.044 – volume: 52 start-page: 472 year: 1973 ident: 10.1016/j.jaci.2013.12.1088_bib37 article-title: IgE antibody measurements in ragweed hay fever. Relationship to clinical severity and the results of immunotherapy publication-title: J Clin Invest doi: 10.1172/JCI107204 – volume: 36 start-page: 380 year: 2006 ident: 10.1016/j.jaci.2013.12.1088_bib27 article-title: Regulation of T cells and cytokines by the interleukin-10 (IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26 publication-title: Eur J Immunol doi: 10.1002/eji.200425523 – volume: 211 start-page: 590 year: 2007 ident: 10.1016/j.jaci.2013.12.1088_bib85 article-title: The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road publication-title: J Cell Physiol doi: 10.1002/jcp.21001 – volume: 56 start-page: 456 year: 1986 ident: 10.1016/j.jaci.2013.12.1088_bib35 article-title: Specific IgE response with a standardized allergen or allergoid in grass pollen allergy publication-title: Ann Allergy – volume: 141 start-page: 346 year: 2006 ident: 10.1016/j.jaci.2013.12.1088_bib21 article-title: Basophil interleukin 4 and interleukin 13 production is suppressed during the early phase of rush immunotherapy publication-title: Int Arch Allergy Immunol doi: 10.1159/000095461 – volume: 69 start-page: 489 year: 1982 ident: 10.1016/j.jaci.2013.12.1088_bib41 article-title: Clinical relevance of the venom-specific immunoglobulin G antibody level during immunotherapy publication-title: J Allergy Clin Immunol doi: 10.1016/0091-6749(82)90172-5 – volume: 131 start-page: 14 year: 2013 ident: 10.1016/j.jaci.2013.12.1088_bib5 article-title: Can we produce true tolerance in patients with food allergy? publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2012.10.058 – volume: 441 start-page: 231 year: 2006 ident: 10.1016/j.jaci.2013.12.1088_bib86 article-title: Transforming growth factor-beta induces development of the T(H)17 lineage publication-title: Nature doi: 10.1038/nature04754 – volume: 131 start-page: 1479 year: 2013 ident: 10.1016/j.jaci.2013.12.1088_bib18 article-title: Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2013.02.036 – volume: 4 start-page: 313 year: 2004 ident: 10.1016/j.jaci.2013.12.1088_bib40 article-title: Mechanisms of immunotherapy: IgG revisited publication-title: Curr Opin Allergy Clin Immunol – volume: 132 start-page: 527 year: 2013 ident: 10.1016/j.jaci.2013.12.1088_bib62 article-title: Natural killer cells in patients with allergic diseases publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2013.07.030 – volume: 30 start-page: 1683 year: 2000 ident: 10.1016/j.jaci.2013.12.1088_bib91 article-title: IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway publication-title: Eur J Immunol doi: 10.1002/1521-4141(200006)30:6<1683::AID-IMMU1683>3.0.CO;2-A – volume: 44 start-page: 412 year: 1989 ident: 10.1016/j.jaci.2013.12.1088_bib42 article-title: Predictive value of venom-specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom publication-title: Allergy doi: 10.1111/j.1398-9995.1989.tb04172.x – volume: 99 start-page: 551 year: 1997 ident: 10.1016/j.jaci.2013.12.1088_bib48 article-title: Priming of eosinophil adhesion in patients with birch pollen allergy during pollen season: effect of immunotherapy publication-title: J Allergy Clin Immunol doi: 10.1016/S0091-6749(97)70084-8 – volume: 22 start-page: 531 year: 2004 ident: 10.1016/j.jaci.2013.12.1088_bib68 article-title: Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.21.120601.141122 – volume: 120 start-page: 76 year: 2007 ident: 10.1016/j.jaci.2013.12.1088_bib90 article-title: IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1 publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2007.04.004 – volume: 68 start-page: 825 year: 2013 ident: 10.1016/j.jaci.2013.12.1088_bib2 article-title: Allergen immunotherapy: a new semantic framework from the European Academy of Allergy and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL consensus report publication-title: Allergy doi: 10.1111/all.12180 – volume: 18 start-page: 736 year: 2012 ident: 10.1016/j.jaci.2013.12.1088_bib6 article-title: Therapies for allergic inflammation: refining strategies to induce tolerance publication-title: Nat Med doi: 10.1038/nm.2754 – volume: 132 start-page: 13 year: 2003 ident: 10.1016/j.jaci.2013.12.1088_bib39 article-title: Renaissance of the blocking antibody concept in type I allergy publication-title: Int Arch Allergy Immunol doi: 10.1159/000073260 – volume: 33 start-page: 1205 year: 2003 ident: 10.1016/j.jaci.2013.12.1088_bib30 article-title: IL-10 and TGF-b cooperate in regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy publication-title: Eur J Immunol doi: 10.1002/eji.200322919 – volume: 62 start-page: 425 year: 2013 ident: 10.1016/j.jaci.2013.12.1088_bib13 article-title: Mechanisms of allergen-specific immunotherapy and novel ways for vaccine development publication-title: Allergol Int doi: 10.2332/allergolint.13-RAI-0608 – volume: 112 start-page: 1310 year: 2003 ident: 10.1016/j.jaci.2013.12.1088_bib71 article-title: The origin of FOXP3-expressing CD4+ regulatory T cells: thymus or periphery publication-title: J Clin Invest doi: 10.1172/JCI200320274 – volume: 1 start-page: 1349 year: 1999 ident: 10.1016/j.jaci.2013.12.1088_bib89 article-title: TGF-beta and fibrosis publication-title: Microbes Infect doi: 10.1016/S1286-4579(99)00250-6 – volume: 129 start-page: 510 year: 2012 ident: 10.1016/j.jaci.2013.12.1088_bib83 article-title: Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2011.09.031 – volume: 10 start-page: 801 year: 2004 ident: 10.1016/j.jaci.2013.12.1088_bib66 article-title: Regulatory T cells and mechanisms of immune system control publication-title: Nat Med doi: 10.1038/nm0804-801 – volume: 242 start-page: 51 year: 2011 ident: 10.1016/j.jaci.2013.12.1088_bib12 article-title: Allergens and their role in the allergic immune response publication-title: Immunol Rev doi: 10.1111/j.1600-065X.2011.01021.x – volume: 309 start-page: 1278 year: 2013 ident: 10.1016/j.jaci.2013.12.1088_bib4 article-title: Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review publication-title: JAMA doi: 10.1001/jama.2013.2049 – volume: 136 start-page: 134 year: 2005 ident: 10.1016/j.jaci.2013.12.1088_bib104 article-title: Lack of detectable alterations in immune responses during sublingual immunotherapy in children with seasonal allergic rhinoconjunctivitis to grass pollen publication-title: Int Arch Allergy Immunol doi: 10.1159/000083320 – volume: 482 start-page: 395 year: 2012 ident: 10.1016/j.jaci.2013.12.1088_bib59 article-title: Extrathymically generated regulatory T cells control mucosal TH2 inflammation publication-title: Nature doi: 10.1038/nature10772 – volume: 2 start-page: 301 year: 2001 ident: 10.1016/j.jaci.2013.12.1088_bib67 article-title: Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide publication-title: Nat Immunol doi: 10.1038/86302 – volume: 205 start-page: 2887 year: 2008 ident: 10.1016/j.jaci.2013.12.1088_bib11 article-title: In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure publication-title: J Exp Med doi: 10.1084/jem.20080193 – volume: 413 start-page: 420 year: 2001 ident: 10.1016/j.jaci.2013.12.1088_bib96 article-title: Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors publication-title: Nature doi: 10.1038/35096564 – volume: 5 start-page: e329 year: 2007 ident: 10.1016/j.jaci.2013.12.1088_bib84 article-title: GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells publication-title: PLoS Biol doi: 10.1371/journal.pbio.0050329 – volume: 146 start-page: 1829 year: 1991 ident: 10.1016/j.jaci.2013.12.1088_bib51 article-title: T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma publication-title: J Immunol doi: 10.4049/jimmunol.146.6.1829 – volume: 27 start-page: 860 year: 1997 ident: 10.1016/j.jaci.2013.12.1088_bib47 article-title: Clinical efficacy of specific immunotherapy to cat dander: a double-blind placebo-controlled trial publication-title: Clin Exp Allergy doi: 10.1111/j.1365-2222.1997.tb01225.x – volume: 17 start-page: 1089 year: 2003 ident: 10.1016/j.jaci.2013.12.1088_bib99 article-title: Histamine enhances TGF-beta1-mediated suppression of Th2 responses publication-title: FASEB J doi: 10.1096/fj.02-1008com – volume: 127 start-page: 509 year: 2011 ident: 10.1016/j.jaci.2013.12.1088_bib23 article-title: Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2010.12.1080 – volume: 152 start-page: 4368 year: 1994 ident: 10.1016/j.jaci.2013.12.1088_bib56 article-title: B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10 publication-title: J Immunol doi: 10.4049/jimmunol.152.9.4368 – volume: 206 start-page: 2701 year: 2009 ident: 10.1016/j.jaci.2013.12.1088_bib74 article-title: Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells publication-title: J Exp Med doi: 10.1084/jem.20090596 – volume: 102 start-page: 98 year: 1998 ident: 10.1016/j.jaci.2013.12.1088_bib24 article-title: Role of interleukin 10 in specific immunotherapy publication-title: J Clin Invest doi: 10.1172/JCI2250 – volume: 18 start-page: 718 year: 2006 ident: 10.1016/j.jaci.2013.12.1088_bib7 article-title: Allergy and hypersensitivity: mechanisms of allergic disease publication-title: Curr Opin Immunol – volume: 3 start-page: 253 year: 2003 ident: 10.1016/j.jaci.2013.12.1088_bib65 article-title: Natural versus adaptive regulatory T cells publication-title: Nat Rev Immunol doi: 10.1038/nri1032 – volume: 131 start-page: 1288 year: 2013 ident: 10.1016/j.jaci.2013.12.1088_bib1 article-title: Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2013.01.049 – volume: 25 start-page: 704 year: 1995 ident: 10.1016/j.jaci.2013.12.1088_bib20 article-title: Tryptase and histamine release due to a sting challenge in bee venom allergic patients treated successfully or unsuccessfully with hyposensitization publication-title: Clin Exp Allergy doi: 10.1111/j.1365-2222.1995.tb00007.x – volume: 97 start-page: 1122 year: 1996 ident: 10.1016/j.jaci.2013.12.1088_bib55 article-title: Interleukin (IL)-10 Inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells publication-title: J Clin Invest doi: 10.1172/JCI118506 – volume: 120 start-page: 960 year: 2007 ident: 10.1016/j.jaci.2013.12.1088_bib77 article-title: Circulating Foxp3+CD4+ cell numbers in atopic patients and healthy control subjects publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2007.05.036 – volume: 13 start-page: 461 year: 2013 ident: 10.1016/j.jaci.2013.12.1088_bib72 article-title: The plasticity and stability of regulatory T cells publication-title: Nat Rev Immunol doi: 10.1038/nri3464 – volume: 1 start-page: 85 year: 2001 ident: 10.1016/j.jaci.2013.12.1088_bib98 article-title: Regulation of interleukin-10 secretion by histamine in TH2 cells and splenocytes publication-title: Int Immunopharmacol doi: 10.1016/S0162-3109(00)00268-X – volume: 8 start-page: 645 year: 2009 ident: 10.1016/j.jaci.2013.12.1088_bib10 article-title: Therapeutic manipulation of immune tolerance in allergic disease publication-title: Nat Rev Drug Discov doi: 10.1038/nrd2653 – volume: 19 start-page: 399 year: 1989 ident: 10.1016/j.jaci.2013.12.1088_bib45 article-title: Suppression of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus) publication-title: Clin Exp Allergy doi: 10.1111/j.1365-2222.1989.tb02405.x – volume: 197 start-page: 489 year: 2003 ident: 10.1016/j.jaci.2013.12.1088_bib61 article-title: Prevention of arthritis by interleukin 10-producing B cells publication-title: J Exp Med doi: 10.1084/jem.20021293 – volume: 27 start-page: 68 year: 1997 ident: 10.1016/j.jaci.2013.12.1088_bib34 article-title: Measurement of IgE antibodies against purified grass pollen allergens (Lol p 1, 2, 3 and 5) during immunotherapy publication-title: Clin Exp Allergy doi: 10.1111/j.1365-2222.1997.tb00674.x – volume: 106 start-page: R75 year: 2000 ident: 10.1016/j.jaci.2013.12.1088_bib75 article-title: JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome publication-title: J Clin Invest doi: 10.1172/JCI11679 – volume: 131 start-page: 875 year: 2013 ident: 10.1016/j.jaci.2013.12.1088_bib82 article-title: Triggering of specific Toll-like receptors and proinflammatory cytokines breaks allergen-specific T-cell tolerance in human tonsils and peripheral blood publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2012.10.051 – volume: 46 start-page: 622 year: 2009 ident: 10.1016/j.jaci.2013.12.1088_bib92 article-title: IL-10 suppresses CD2-mediated T cell activation via SHP-1 publication-title: Mol Immunol doi: 10.1016/j.molimm.2008.07.031 – volume: 82 start-page: 439 year: 1988 ident: 10.1016/j.jaci.2013.12.1088_bib38 article-title: Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy publication-title: J Allergy Clin Immunol doi: 10.1016/0091-6749(88)90017-6 – volume: 22 start-page: 329 year: 2005 ident: 10.1016/j.jaci.2013.12.1088_bib73 article-title: Regulatory T cell lineage specification by the forkhead transcription factor foxp3 publication-title: Immunity doi: 10.1016/j.immuni.2005.01.016 – volume: 108 start-page: 1865 year: 2001 ident: 10.1016/j.jaci.2013.12.1088_bib97 article-title: Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization publication-title: J Clin Invest doi: 10.1172/JCI200113930 – volume: 131 start-page: 1204 year: 2013 ident: 10.1016/j.jaci.2013.12.1088_bib28 article-title: IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2013.01.014 – volume: 129 start-page: 1020 year: 2012 ident: 10.1016/j.jaci.2013.12.1088_bib87 article-title: A regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapy publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2012.02.014 – year: 2013 ident: 10.1016/j.jaci.2013.12.1088_bib8 article-title: Immune tolerance – volume: 198 start-page: 1875 year: 2003 ident: 10.1016/j.jaci.2013.12.1088_bib69 article-title: Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 publication-title: J Exp Med doi: 10.1084/jem.20030152 – volume: 127 start-page: 355 year: 2011 ident: 10.1016/j.jaci.2013.12.1088_bib17 article-title: Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2010.11.037 – volume: 181 start-page: 5396 year: 2008 ident: 10.1016/j.jaci.2013.12.1088_bib81 article-title: The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation publication-title: J Immunol doi: 10.4049/jimmunol.181.8.5396 – volume: 61 start-page: 1184 year: 2006 ident: 10.1016/j.jaci.2013.12.1088_bib105 article-title: Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC publication-title: Allergy doi: 10.1111/j.1398-9995.2006.01206.x – volume: 58 start-page: 657 year: 2003 ident: 10.1016/j.jaci.2013.12.1088_bib107 article-title: Effects on inflammation parameters of a double-blind, placebo controlled one-year course of SLIT in children monosensitized to mites publication-title: Allergy doi: 10.1034/j.1398-9995.2003.00193.x – volume: 76 start-page: 2247 year: 1985 ident: 10.1016/j.jaci.2013.12.1088_bib49 article-title: Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy publication-title: J Clin Invest doi: 10.1172/JCI112233 – volume: 111 start-page: 1255 year: 2003 ident: 10.1016/j.jaci.2013.12.1088_bib32 article-title: Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy publication-title: J Allergy Clin Immunol doi: 10.1067/mai.2003.1570 – volume: 27 start-page: 20 year: 2001 ident: 10.1016/j.jaci.2013.12.1088_bib76 article-title: The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 publication-title: Nat Genet doi: 10.1038/83713 – volume: 116 start-page: 608 year: 2005 ident: 10.1016/j.jaci.2013.12.1088_bib44 article-title: Allergen-specific immunotherapy with recombinant grass pollen allergens publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2005.06.004 – volume: 204 start-page: 105 year: 2007 ident: 10.1016/j.jaci.2013.12.1088_bib80 article-title: Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand publication-title: J Exp Med doi: 10.1084/jem.20061660 |
| SSID | ssj0009389 |
| Score | 2.6029139 |
| SecondaryResourceType | review_article |
| Snippet | Allergen-specific immunotherapy (AIT) has been used for more than 100 years as a desensitizing therapy for IgE-mediated allergic diseases and represents a... Allergen-specific immunotherapy (AIT) has been used for more than 100 years as a desensitizing therapy for IgE-mediated allergic diseases and represents a... |
| SourceID | proquest pubmed pascalfrancis crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 621 |
| SubjectTerms | allergen immunotherapy Allergens - immunology Allergies Allergy and Immunology Animals Asthma B cells B-Lymphocytes, Regulatory - immunology basophils Basophils - physiology Biological and medical sciences Biopsy Cytokines Desensitization, Immunologic Disease eosinophils Food allergies Forkhead Transcription Factors - physiology Fundamental and applied biological sciences. Psychology Fundamental immunology Humans IgE IgG IL-10 Immune system Immune Tolerance Immunopathology Immunotherapy Interleukin-10 - physiology Ligands Lymphocytes mast cells Mast Cells - physiology Medical sciences Psoriasis Receptors, Histamine H2 - physiology Regulatory T cells Rodents Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis T cells T helper cells T-Lymphocytes, Regulatory - immunology TGF-β Transcription factors Transforming Growth Factor beta - physiology |
| Title | Mechanisms of allergen-specific immunotherapy: Multiple suppressor factors at work in immune tolerance to allergens |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0091674914001067 https://www.clinicalkey.es/playcontent/1-s2.0-S0091674914001067 https://dx.doi.org/10.1016/j.jaci.2013.12.1088 https://www.ncbi.nlm.nih.gov/pubmed/24581429 https://www.proquest.com/docview/1644784553 https://www.proquest.com/docview/1514438833 https://www.proquest.com/docview/1654674883 |
| Volume | 133 |
| WOSCitedRecordID | wos000332397600002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1097-6825 dateEnd: 20200131 omitProxy: false ssIdentifier: ssj0009389 issn: 0091-6749 databaseCode: AIEXJ dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ti9NAEF56dyKCiG-n1bNEEL9ojrxv1m-13KFyrYI96Ldls9lAay-tTXsc_gJ_tjPZTXKl13p-kEIIyb4182R2djMzDyFvYEqiirmp7foitQNBFRK5C5tmCWZ3ypIgkiXZBB0M4tGIfWu1flexMJdTmufx1RWb_1dRwzUQNobO_oO460bhApyD0OEIYofjrQTfVxjMOy4uSicNpErB-EobQyrRLejdGCNCTNxVme6p9iksVvPSLXa2qGl4xLIkk8FdkbIeEm1Ag2WcAVitVevFFhtX39cpnuoYTD2A67v53R-pTnXQx-_2H3socTXduNtTvy7GZvPVbFS4QeOpZXSrw6gdxTrO-VjdcK1SyDo1hkGef029RjqaekPt6x2IyfFEyDG66_m4xes6mjBwPcn24Cs_PT8748OT0fDt_KeN_GP4nd6QseyRA4-GDPTjQffzyehLk8DZL-kU6wFXGaxKX8GNfrdZOffnooAnnWnSlO2rmtK6GT4kD4zIrK6G0yPSUvljcrdvHC-ekKJBlTXLrA1UWWuo-mBVmLIaTFkGU5ZYWogpa5zrWsqqMQVnddvFU3J-ejLsfbINX4ctwYhe2qnjKyoZVT5NE5nhalQmaSBhLg7TxElUwjLmxjIKZSoT5iknS-MsdBIhPJbAWuCQ7OezXD0nVsyElAFTKnZFgByyfoTkkcrB7Ygkc9vEq54vlyaZPXKqTHnltTjhKBSOQuGuh3lw4zZ5X1ea61wuu4sHleB49YrAxMoBdLur0ZuqqcLoiIK7vPC4w78DqDAGiLmBzuTYJlFd09i_2q79e5edNVzV_w7WDvCLojY5qoDGm2HAUojGQRj6bfK6vg2zC34yFLmaraAMrKcCHwnJd5TBeEgKhgCUeaZB3AwgCGMXTN4Xt-jhJbnXqI0jsr9crNQrckdeLsfFokP26CjumLfyD6NcCmE |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mechanisms+of+allergen-specific+immunotherapy%3A+multiple+suppressor+factors+at+work+in+immune+tolerance+to+allergens&rft.jtitle=Journal+of+allergy+and+clinical+immunology&rft.au=Akdis%2C+M%C3%BCbeccel&rft.au=Akdis%2C+Cezmi+A&rft.date=2014-03-01&rft.issn=1097-6825&rft.eissn=1097-6825&rft.volume=133&rft.issue=3&rft.spage=621&rft_id=info:doi/10.1016%2Fj.jaci.2013.12.1088&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_m | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00916749%2FS0091674913X0017X%2Fcov150h.gif |